status: 200
x-ah-environment: prod
via: 1.1 varnish
vary: Cookie,Accept-Encoding
content-length: 96798
x-request-id: v-259ef63c-799d-11e6-85a7-22000a24d0aa
content-language: en
etag: "1473758978-1"
x-cache-hits: 11
cache-control: public, max-age=3600
x-varnish: 1884191043 1884115944
x-cache: HIT
accept-ranges: bytes
expires: Sun, 19 Nov 1978 05:00:00 GMT
last-modified: Tue, 13 Sep 2016 09:29:38 GMT
-content-encoding: gzip
date: Tue, 13 Sep 2016 11:00:48 GMT
x-drupal-cache: HIT
content-location: http://www.cancertechnology.co.uk/
age: 1795
server: nginx
connection: keep-alive
content-type: text/html; charset=utf-8
-varied-accept-encoding: gzip, deflate

<!DOCTYPE html>
<!--[if lt IE 7]>  <html class="ie ie6 lte9 lte8 lte7" lang="en"> <![endif]-->
<!--[if IE 7]>     <html class="ie ie7 lte9 lte8 lte7" lang="en"> <![endif]-->
<!--[if IE 8]>     <html class="ie ie8 lte9 lte8" lang="en"> <![endif]-->
<!--[if IE 9]>     <html class="ie ie9 lte9" lang="en"> <![endif]-->
<!--[if gt IE 9]>  <html class="ie" lang="en"> <![endif]-->
<!--[if !IE]><!--> <html lang="en"> <!--<![endif]-->

<!-- <html xmlns="http://www.w3.org/1999/xhtml"> -->
<!-- <head profile=""> -->

<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<link rel="shortcut icon" href="http://www.cancertechnology.co.uk/sites/default/files/favicon.ico" type="image/vnd.microsoft.icon" />
<link rel="alternate" type="application/rss+xml" title="Cancer Research Technology RSS" href="http://www.cancertechnology.co.uk/rss.xml" />
  <title>Cancer Research Technology</title>

  <meta name="viewport" content="width=device-width, initial-scale=1">

  <link type="text/css" rel="stylesheet" href="http://www.cancertechnology.co.uk/sites/default/files/css/css_xE-rWrJf-fncB6ztZfd2huxqgxu4WO-qwma6Xer30m4.css" media="all" />
<link type="text/css" rel="stylesheet" href="http://www.cancertechnology.co.uk/sites/default/files/css/css_8I8tOCPjIVP6mfeMJ_e9IPVH1CnLb6wMloNuja55pnc.css" media="all" />
<link type="text/css" rel="stylesheet" href="http://www.cancertechnology.co.uk/sites/default/files/css/css_YEtwitmBNJScwhiRxc89obxLSa1wsA0kvXbtM2jgIJI.css" media="all" />
<link type="text/css" rel="stylesheet" href="//maxcdn.bootstrapcdn.com/font-awesome/4.5.0/css/font-awesome.min.css" media="all" />
<link type="text/css" rel="stylesheet" href="http://www.cancertechnology.co.uk/sites/default/files/css/css_knFyAST7iN7Fss0aJN_p9Q-5aoMKBDwEs0KeLhHhnIs.css" media="all" />
<link type="text/css" rel="stylesheet" href="http://www.cancertechnology.co.uk/sites/default/files/css/css_x_IZzm6w7_sXaP9cEcS1VoIV4svfPb3cxRImd8C--48.css" media="all" />
  <script type="text/javascript" src="http://www.cancertechnology.co.uk/sites/default/files/js/js_fygC93yEjQGcLkScNKn_QwV_YyDsSD7QeocMmJhd8ys.js"></script>
<script type="text/javascript" src="http://www.cancertechnology.co.uk/sites/default/files/js/js_ggmusuASVZPx0sSTAzV-Oqx_IpjOaHk-0b3uNurJOX4.js"></script>
<script type="text/javascript" src="http://www.cancertechnology.co.uk/sites/default/files/js/js_m1-TudMRNqg0tdpkZahcN8tdrGicxy5Ccj3wxCw1ht0.js"></script>
<script type="text/javascript" src="http://www.cancertechnology.co.uk/sites/all/modules/lightbox2/js/lightbox.js?1473758978"></script>
<script type="text/javascript" src="http://www.cancertechnology.co.uk/sites/default/files/js/js_ZpFKNfPUzwy8T49E3w9NE1S-QEFNjaSWoJItDlN2JOQ.js"></script>
<script type="text/javascript" src="http://www.cancertechnology.co.uk/sites/default/files/js/js_3V2bC1g-ruSMmH6-dRrVpLXCIC1KSReL0HrAR3qaS8Q.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
jQuery.extend(Drupal.settings, {"basePath":"\/","pathPrefix":"","ajaxPageState":{"theme":"cdg","theme_token":"HLx19ZcyJExuMJvrw7IwbohgiZONr0szCy_v3VVKPts","js":{"sites\/default\/files\/minify\/jquery.1.4.4.min.js":1,"sites\/default\/files\/minify\/jquery.once.1.2.min.js":1,"sites\/default\/files\/minify\/drupal.min.js":1,"sites\/default\/files\/minify\/jquery.cookie.1.0.min.js":1,"sites\/default\/files\/minify\/jquery.form.2.52.min.js":1,"sites\/default\/files\/minify\/ajax.7.37.min.js":1,"sites\/default\/files\/minify\/progress.7.37.min.js":1,"sites\/default\/files\/minify\/jquery.colorbox-min.min.js":1,"sites\/default\/files\/minify\/colorbox.min.js":1,"sites\/default\/files\/minify\/colorbox_style.min.js":1,"sites\/all\/modules\/lightbox2\/js\/lightbox.js":1,"sites\/default\/files\/minify\/megamenu.min.js":1,"sites\/default\/files\/minify\/custom_search.min.js":1,"sites\/default\/files\/minify\/base.min.js":1,"sites\/default\/files\/minify\/ajax_view.min.js":1,"sites\/default\/files\/minify\/quicktabs.min.js":1,"sites\/all\/themes\/CRT-2013\/assets\/vendor\/jquery\/jquery.min.js":1,"sites\/all\/themes\/CRT-2013\/assets\/js\/common.js":1,"sites\/all\/themes\/CRT-2013\/assets\/vendor\/bootstrap-sass-official\/assets\/javascripts\/bootstrap.min.js":1},"css":{"modules\/system\/system.base.css":1,"modules\/system\/system.menus.css":1,"modules\/system\/system.messages.css":1,"modules\/system\/system.theme.css":1,"sites\/all\/modules\/date\/date_api\/date.css":1,"sites\/all\/modules\/date\/date_popup\/themes\/datepicker.1.7.css":1,"modules\/field\/theme\/field.css":1,"modules\/node\/node.css":1,"modules\/search\/search.css":1,"modules\/user\/user.css":1,"sites\/all\/modules\/views\/css\/views.css":1,"sites\/all\/modules\/ckeditor\/css\/ckeditor.css":1,"sites\/all\/modules\/colorbox\/styles\/default\/colorbox_style.css":1,"sites\/all\/modules\/ctools\/css\/ctools.css":1,"sites\/all\/modules\/lightbox2\/css\/lightbox.css":1,"sites\/all\/modules\/custom\/megamenu\/megamenu.css":1,"sites\/all\/modules\/custom\/megamenu\/megamenu-skins.css":1,"sites\/all\/modules\/panels\/css\/panels.css":1,"sites\/all\/modules\/custom_search\/custom_search.css":1,"\/\/maxcdn.bootstrapcdn.com\/font-awesome\/4.5.0\/css\/font-awesome.min.css":1,"sites\/all\/modules\/quicktabs\/css\/quicktabs.css":1,"sites\/all\/themes\/CRT-2013\/assets\/css\/styles.css":1,"sites\/all\/themes\/CRT-2013\/assets\/css\/styles.override.css":1,"sites\/all\/themes\/CRT-2013\/assets\/css\/styles.phase2.css":1}},"colorbox":{"opacity":"0.85","current":"{current} of {total}","previous":"\u00ab Prev","next":"Next \u00bb","close":"Close","maxWidth":"98%","maxHeight":"98%","fixed":true,"mobiledetect":true,"mobiledevicewidth":"480px"},"lightbox2":{"rtl":0,"file_path":"\/(\\w\\w\/)public:\/","default_image":"\/sites\/all\/modules\/lightbox2\/images\/brokenimage.jpg","border_size":10,"font_color":"000","box_color":"fff","top_position":"","overlay_opacity":"0.8","overlay_color":"000","disable_close_click":true,"resize_sequence":0,"resize_speed":400,"fade_in_speed":400,"slide_down_speed":600,"use_alt_layout":false,"disable_resize":false,"disable_zoom":false,"force_show_nav":false,"show_caption":true,"loop_items":false,"node_link_text":"View Image Details","node_link_target":false,"image_count":"Image !current of !total","video_count":"Video !current of !total","page_count":"Page !current of !total","lite_press_x_close":"press \u003Ca href=\u0022#\u0022 onclick=\u0022hideLightbox(); return FALSE;\u0022\u003E\u003Ckbd\u003Ex\u003C\/kbd\u003E\u003C\/a\u003E to close","download_link_text":"","enable_login":false,"enable_contact":false,"keys_close":"c x 27","keys_previous":"p 37","keys_next":"n 39","keys_zoom":"z","keys_play_pause":"32","display_image_size":"original","image_node_sizes":"()","trigger_lightbox_classes":"","trigger_lightbox_group_classes":"","trigger_slideshow_classes":"","trigger_lightframe_classes":"","trigger_lightframe_group_classes":"","custom_class_handler":0,"custom_trigger_classes":"","disable_for_gallery_lists":true,"disable_for_acidfree_gallery_lists":true,"enable_acidfree_videos":true,"slideshow_interval":5000,"slideshow_automatic_start":true,"slideshow_automatic_exit":true,"show_play_pause":true,"pause_on_next_click":false,"pause_on_previous_click":true,"loop_slides":false,"iframe_width":600,"iframe_height":400,"iframe_border":1,"enable_video":false},"megamenu":{"timeout":"500","sizewait":"250","hoverwait":"400"},"custom_search":{"form_target":"_self","solr":0},"urlIsAjaxTrusted":{"\/events":true,"\/":true},"views":{"ajax_path":"\/views\/ajax","ajaxViews":{"views_dom_id:3443010a0dc64dc7afdf17893794a268":{"view_name":"events","view_display_id":"block_2","view_args":"","view_path":"node","view_base_path":"events","view_dom_id":"3443010a0dc64dc7afdf17893794a268","pager_element":0}}},"quicktabs":{"qt_front_page_tabs":{"name":"front_page_tabs","tabs":[{"vid":"press_release","display":"block_3","args":"","view_path":"node","view_dom_id":1,"ajax_args":"","actual_args":[]},{"vid":"events","display":"block_2","args":"","view_path":"node","view_dom_id":2,"ajax_args":"","actual_args":[]},{"bid":"block_delta_14","hide_title":1}],"custom_search":{"form_target":"_self","solr":0}}}});
//--><!]]>
</script>

	<script type="text/javascript" src="//use.typekit.net/ucs7ntp.js"></script>
	<script type="text/javascript">//try{Typekit.load();}catch(e){}</script>

<!-- Google Tag Manager -->
<noscript><iframe src="//www.googletagmanager.com/ns.html?id=GTM-5CSR6V"
height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
<script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
'//www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
})(window,document,'script','dataLayer','GTM-5CSR6V');</script>
<!-- End Google Tag Manager -->

<!--[if lt IE 9]>
  <script>
    document.createElement('header');
    document.createElement('section');
    document.createElement('article');
    document.createElement('aside');
    document.createElement('nav');
    document.createElement('footer');
  </script>
<![endif]-->
</head>
<body class="html front not-logged-in no-sidebars page-node" >

		<div class="template1"><div id="wrapper"><div id="uberContainer"> <header><h1><a href="/">Cancer Research Technology</a></h1><div class="hidden-xs"><form class="search-form" role="search" onsubmit="if(this.search_block_form.value==&#039;Site search&#039;){ alert(&#039;Please enter a search&#039;); return false; }" action="/" method="post" id="search-block-form" accept-charset="UTF-8"><div><div class="container-inline"><h2 class="element-invisible">Search form</h2><div class="form-item form-type-textfield form-item-search-block-form"> <label class="element-invisible" for="edit-search-block-form--2">Search </label> <input title="Enter the terms you wish to search for." class="custom-search-box form-text" placeholder="Site search" onblur="if (this.value == &#039;&#039;) {this.value = &#039;Site search&#039;;}" onfocus="if (this.value == &#039;Site search&#039;) {this.value = &#039;&#039;;}" type="text" id="edit-search-block-form--2" name="search_block_form" value="Site search" size="40" maxlength="128" /></div><div class="form-actions form-wrapper" id="edit-actions"><input type="submit" id="edit-submit" name="op" value="" class="form-submit" /></div><input type="hidden" name="form_build_id" value="form-_MB4V_bJ6tdniWd-DMDFoi87cEsuq4VSh38fQrNTAxA" /><input type="hidden" name="form_id" value="search_block_form" /></div></div></form></div><p class="tagline">Advancing discoveries to beat cancer</p> </header> <nav role="navigation" class="megamenu hidden-xs"><ul id="megamenu-main-menu" class="megamenu-menu columnar megamenu-skin-friendly"><li id="megamenu-mlid-218" class="megamenu-parent menuitem megamenu-parent-0 odd half-1 leaf-0 first menu-218 first"><a href="/" class="active">Home</a><span class="arrow"></span><span class="highlight"></span></li><li id="megamenu-mlid-942" class="megamenu-parent menuitem megamenu-parent-1 even half-1 leaf-1 menu-942 "><a href="/our-company">About CRT</a><span class="arrow"></span><span class="highlight"></span><ul class="submenu megamenu-bin megamenu-slots-columnar"><li id="megamenu-mlid-943" class="megamenu-slot megamenu-slot-0 odd half-1 leaf-0 first first"><span class="megamenu-slot-title"><a href="/our-company">Our Company</a></span></li><li id="megamenu-mlid-828" class="megamenu-slot megamenu-slot-1 even half-1 leaf-1 "><span class="megamenu-slot-title"><a href="/our-people">Our People</a></span></li><li id="megamenu-mlid-839" class="megamenu-slot megamenu-slot-2 odd half-2 leaf-2 "><span class="megamenu-slot-title"><a href="/our-network">Our Network</a></span></li><li id="megamenu-mlid-827" class="megamenu-slot megamenu-slot-3 even half-2 leaf-3 last last"><span class="megamenu-slot-title"><a href="/our-history">Our History</a></span></li></ul></li><li id="megamenu-mlid-835" class="megamenu-parent menuitem megamenu-parent-2 odd half-1 leaf-2 menu-835 "><a href="/services">Services</a><span class="arrow"></span><span class="highlight"></span><ul class="submenu megamenu-bin megamenu-slots-columnar"><li id="megamenu-mlid-841" class="megamenu-slot megamenu-slot-0 odd half-1 leaf-0 first first"><span class="megamenu-slot-title"><a href="/services">Overview</a></span></li><li id="megamenu-mlid-831" class="megamenu-slot megamenu-slot-1 even half-1 leaf-1 "><span class="megamenu-slot-title"><a href="/project-development">Project Development</a></span><ul class="megamenu-items "><li id="megamenu-mlid-842" class="megamenu-item megamenu-item-0 odd half-1 leaf-0 first first last"><a href="/have-idea">Have an idea?</a></li></ul></li><li id="megamenu-mlid-845" class="megamenu-slot megamenu-slot-2 odd half-1 leaf-2 "><span class="megamenu-slot-title"><a href="/commercialisation">Commercialisation</a></span></li><li id="megamenu-mlid-847" class="megamenu-slot megamenu-slot-3 even half-1 leaf-3 "><span class="megamenu-slot-title"><a href="/drug-discovery">Drug Discovery</a></span><ul class="megamenu-items "><li id="megamenu-mlid-1047" class="megamenu-item megamenu-item-0 odd half-1 leaf-0 first first last"><a href="/cruk-drug-discovery">CRUK Drug Discovery</a></li></ul></li><li id="megamenu-mlid-851" class="megamenu-slot megamenu-slot-4 odd half-2 leaf-4 "><span class="megamenu-slot-title"><a href="/clinical-development">Clinical Development</a></span><ul class="megamenu-items "><li id="megamenu-mlid-826" class="megamenu-item megamenu-item-0 odd half-1 leaf-0 first first last"><a href="/cdp">CDP</a></li></ul></li><li id="megamenu-mlid-818" class="megamenu-slot megamenu-slot-5 even half-2 leaf-5 "><span class="megamenu-slot-title"><a href="/imaging">Imaging</a></span></li><li id="megamenu-mlid-976" class="megamenu-slot megamenu-slot-6 odd half-2 leaf-6 last last"><span class="megamenu-slot-title"><a href="/funding">Funding</a></span></li></ul></li><li id="megamenu-mlid-836" class="megamenu-parent menuitem megamenu-parent-3 even half-1 leaf-3 menu-836 "><a href="/our-projects">Projects</a><span class="arrow"></span><span class="highlight"></span><ul class="submenu megamenu-bin megamenu-slots-columnar"><li id="megamenu-mlid-852" class="megamenu-slot megamenu-slot-0 odd half-1 leaf-0 first first"><span class="megamenu-slot-title"><a href="/our-projects">Overview</a></span></li><li id="megamenu-mlid-829" class="megamenu-slot megamenu-slot-1 even half-1 leaf-1 "><span class="megamenu-slot-title"><a href="/our-pipeline">Our Pipeline</a></span></li><li id="megamenu-mlid-819" class="megamenu-slot megamenu-slot-2 odd half-2 leaf-2 "><span class="megamenu-slot-title"><a href="/licensing-opportunities">Licensing Opportunities</a></span><ul class="megamenu-items "><li id="megamenu-mlid-1036" class="megamenu-item megamenu-item-0 odd half-1 leaf-0 first first"><a href="/lo-small-molecules-search">Small Molecules</a></li><li id="megamenu-mlid-1038" class="megamenu-item megamenu-item-1 even half-1 leaf-1 "><a href="/lo-biological-therapeutics-search">Biological Therapeutics</a></li><li id="megamenu-mlid-1039" class="megamenu-item megamenu-item-2 odd half-1 leaf-2 "><a href="/lo-enabling-technology-search">Enabling Technology</a></li><li id="megamenu-mlid-1042" class="megamenu-item megamenu-item-3 even half-2 leaf-3 "><a href="/lo-medical-devices-search">Medical Devices</a></li><li id="megamenu-mlid-1044" class="megamenu-item megamenu-item-4 odd half-2 leaf-4 last last"><a href="/lo-biomarkers-search">Biomarkers</a></li></ul></li><li id="megamenu-mlid-830" class="megamenu-slot megamenu-slot-3 even half-2 leaf-3 last last"><span class="megamenu-slot-title"><a href="/our-start-ups">Our Start-ups</a></span></li></ul></li><li id="megamenu-mlid-825" class="megamenu-parent menuitem megamenu-parent-4 odd half-2 leaf-4 menu-825 "><a href="/research-tools">Research Tools</a><span class="arrow"></span><span class="highlight"></span><ul class="submenu megamenu-bin megamenu-slots-columnar"><li id="megamenu-mlid-858" class="megamenu-slot megamenu-slot-0 odd half-1 leaf-0 first first last"><span class="megamenu-slot-title"><a href="/research-tools">Research Tools</a></span></li></ul></li><li id="megamenu-mlid-860" class="megamenu-parent menuitem megamenu-parent-5 even half-2 leaf-5 menu-860 "><a href="/news-and-events">News and Events</a><span class="arrow"></span><span class="highlight"></span><ul class="submenu megamenu-bin megamenu-slots-columnar"><li id="megamenu-mlid-816" class="megamenu-slot megamenu-slot-0 odd half-1 leaf-0 first first"><span class="megamenu-slot-title"><a href="/news-and-events">News and Events</a></span><ul class="megamenu-items "><li id="megamenu-mlid-933" class="megamenu-item megamenu-item-0 odd half-1 leaf-0 first first"><a href="/alliance-translational-research-centres-established-accelerate-global-drug-development">Alliance of translational research centres established to accelerate global drug development</a></li><li id="megamenu-mlid-935" class="megamenu-item megamenu-item-1 even half-1 leaf-1 "><a href="/astex-pharmaceuticals-earns-54-m-milestone-phi-trial-initiation-fgfr-kinase-inhibitor">Astex Pharmaceuticals Earns $5.4 M Milestone on PhI Trial Initiation of a FGFR Kinase Inhibitor</a></li><li id="megamenu-mlid-934" class="megamenu-item megamenu-item-2 odd half-1 leaf-2 "><a href="/crt-adc-therapeutics-join-forces-antibody-drug-conjugates">CRT &amp; ADC Therapeutics join forces on Antibody Drug Conjugates</a></li><li id="megamenu-mlid-915" class="megamenu-item megamenu-item-3 even half-1 leaf-3 "><a href="/crt-and-teva-pharmaceuticals-form-rd-alliance-cancer-dna-damage-response-drugs">CRT and Teva Pharmaceuticals Form R&amp;D Alliance for Cancer DNA Damage Response Drugs</a></li><li id="megamenu-mlid-916" class="megamenu-item megamenu-item-4 odd half-1 leaf-4 "><a href="/crt-institute-cancer-research-and-merck-serono-sign-wnt-licensing-deal-0">CRT, The Institute of Cancer Research and Merck Serono sign WNT licensing deal</a></li><li id="megamenu-mlid-873" class="megamenu-item megamenu-item-5 even half-1 leaf-5 "><a href="/cruk-cambridge-institute-symposium">CRUK Cambridge Institute Symposium</a></li><li id="megamenu-mlid-937" class="megamenu-item megamenu-item-6 odd half-1 leaf-6 "><a href="/cancer-research-uk-and-crt-collaborate-abcodia-discover-and-develop-tests-cancer-1">Cancer Research UK and CRT collaborate with Abcodia to discover and develop tests for cancer</a></li><li id="megamenu-mlid-917" class="megamenu-item megamenu-item-7 even half-1 leaf-7 "><a href="/forma-therapeutics-and-crt-discover-cancer-drugs-targeting-deubiquitinating-enzymes-dubs">FORMA Therapeutics and CRT to discover cancer drugs targeting deubiquitinating enzymes (DUBs)</a></li><li id="megamenu-mlid-936" class="megamenu-item megamenu-item-8 odd half-1 leaf-8 "><a href="/new-board-appointment-crt">New board appointment for CRT</a></li><li id="megamenu-mlid-864" class="megamenu-item megamenu-item-9 even half-1 leaf-9 "><a href="/new-offices-crt">New offices for CRT</a></li><li id="megamenu-mlid-1616" class="megamenu-item megamenu-item-10 odd half-1 leaf-10 "><a href="/cruk-research-strategy-great-place-come-and-do-business">&quot;This is a great place to come and do business&quot;</a></li><li id="megamenu-mlid-1228" class="megamenu-item megamenu-item-11 even half-1 leaf-11 "><a href="/2014-bio-international-convention">2014 BIO International Convention</a></li><li id="megamenu-mlid-1331" class="megamenu-item megamenu-item-12 odd half-1 leaf-12 "><a href="/2014-medicinal-chemistry-gordon-research-conference">2014 Medicinal Chemistry Gordon Research Conference</a></li><li id="megamenu-mlid-2816" class="megamenu-item megamenu-item-13 even half-1 leaf-13 "><a href="/2014-year-review-infographic">2014 Year in Review Infographic</a></li><li id="megamenu-mlid-3126" class="megamenu-item megamenu-item-14 odd half-1 leaf-14 "><a href="/2015-bio-international-convention">2015 BIO International Convention</a></li><li id="megamenu-mlid-5451" class="megamenu-item megamenu-item-15 even half-1 leaf-15 "><a href="/2016-bio-international-convention">2016 BIO International Convention</a></li><li id="megamenu-mlid-1596" class="megamenu-item megamenu-item-16 odd half-1 leaf-16 "><a href="/26th-eortc-nci-aacr-symposium">26th EORTC-NCI-AACR SYMPOSIUM</a></li><li id="megamenu-mlid-1224" class="megamenu-item megamenu-item-17 even half-1 leaf-17 "><a href="/aacr-annual-meeting-2014">AACR Annual Meeting</a></li><li id="megamenu-mlid-2846" class="megamenu-item megamenu-item-18 odd half-1 leaf-18 "><a href="/aacr-annual-meeting-2015">AACR Annual Meeting 2015</a></li><li id="megamenu-mlid-4716" class="megamenu-item megamenu-item-19 even half-1 leaf-19 "><a href="/AACR2016">AACR Annual Meeting 2016</a></li><li id="megamenu-mlid-3166" class="megamenu-item megamenu-item-20 odd half-1 leaf-20 "><a href="/aacr-nci-eortc">AACR-NCI-EORTC 2015</a></li><li id="megamenu-mlid-2836" class="megamenu-item megamenu-item-21 even half-1 leaf-21 "><a href="/autm-2015-annual-meeting">AUTM 2015 Annual Meeting</a></li><li id="megamenu-mlid-4711" class="megamenu-item megamenu-item-22 odd half-1 leaf-22 "><a href="/AUTM2016">AUTM 2016 Annual Meeting</a></li><li id="megamenu-mlid-2826" class="megamenu-item megamenu-item-23 even half-1 leaf-23 "><a href="/academic-drug-discovery-workshop">Academic Drug Discovery Workshop</a></li><li id="megamenu-mlid-3796" class="megamenu-item megamenu-item-24 odd half-1 leaf-24 "><a href="/StructuralBiology2016">Accelerator Structural Biology Conference 2016</a></li><li id="megamenu-mlid-1195" class="megamenu-item megamenu-item-25 even half-1 leaf-25 "><a href="/alchemia-announces-licensing-fak-inhibitors-crt">Alchemia announces in-licensing of FAK inhibitors from CRT</a></li><li id="megamenu-mlid-2796" class="megamenu-item megamenu-item-26 odd half-1 leaf-26 "><a href="/bacit-seeks-shareholder-approval-commit-%C2%A320m-and-join-crt-pioneer-fund-limited-partner">BACIT seeks shareholder approval to commit £20m and join CRT Pioneer Fund as a limited partner</a></li><li id="megamenu-mlid-4721" class="megamenu-item megamenu-item-27 even half-1 leaf-27 "><a href="/BioSpring2016">BIO-EUROPE SPRING 2016</a></li><li id="megamenu-mlid-1192" class="megamenu-item megamenu-item-28 odd half-1 leaf-28 "><a href="/bio-europe-spring-2014">BIO-Europe Spring 2014</a></li><li id="megamenu-mlid-3161" class="megamenu-item megamenu-item-29 even half-1 leaf-29 "><a href="/bio-europe-autumn-2015">Bio-Europe 2015</a></li><li id="megamenu-mlid-6071" class="megamenu-item megamenu-item-30 odd half-1 leaf-30 "><a href="/bio-europe-autumn-2016">Bio-Europe Autumn 2016</a></li><li id="megamenu-mlid-6706" class="megamenu-item megamenu-item-31 even half-1 leaf-31 "><a href="/bio-homecoming-2016">Bio-Homecoming 2016</a></li><li id="megamenu-mlid-2841" class="megamenu-item megamenu-item-32 odd half-1 leaf-32 "><a href="/bioinvents-bi-1206-antibody-enter-collaborative-trial">BioInvents BI-1206 antibody to enter collaborative Phase I/II trial</a></li><li id="megamenu-mlid-3121" class="megamenu-item megamenu-item-33 even half-1 leaf-33 "><a href="/biowednesday-future-directions-oncology">BioWednesday: Future Directions in Oncology</a></li><li id="megamenu-mlid-2806" class="megamenu-item megamenu-item-34 odd half-1 leaf-34 "><a href="/biotech-and-money-london-2015">Biotech and Money London 2015</a></li><li id="megamenu-mlid-1656" class="megamenu-item megamenu-item-35 even half-1 leaf-35 "><a href="/biotechs-and-city">Biotechs and the City</a></li><li id="megamenu-mlid-3136" class="megamenu-item megamenu-item-36 odd half-1 leaf-36 "><a href="/crt-highlighted-dowling-review-business-university-research-collaborations">CRT Highlighted in the Dowling Review of Business-University Research Collaborations</a></li><li id="megamenu-mlid-2821" class="megamenu-item megamenu-item-37 even half-1 leaf-37 "><a href="/crt-pioneer-fund-banks-%C2%A320m-investment-bacit-and-expands-agreement-chroma-therapeutics-develop">CRT Pioneer Fund banks £20m investment from BACIT and expands agreement with Chroma Therapeutics</a></li><li id="megamenu-mlid-1126" class="megamenu-item megamenu-item-38 odd half-1 leaf-38 "><a href="/crt-pioneer-fund-collaborates-chroma-therapeutics-develop-cancer-drugs-targeting-immune-system">CRT Pioneer Fund collaborates with Chroma Therapeutics</a></li><li id="megamenu-mlid-1045" class="megamenu-item megamenu-item-39 even half-1 leaf-39 "><a href="/crt-pioneer-fund-bacit-and-sareum-enter-agreement-fund-development-drugs-treat-cancers-including">CRT Pioneer Fund, BACIT and Sareum enter agreement</a></li><li id="megamenu-mlid-6386" class="megamenu-item megamenu-item-40 odd half-1 leaf-40 "><a href="/crt-and-alta-innovations-join-forces-commercialise-world-leading-research">CRT and Alta Innovations join forces to commercialise world-leading research</a></li><li id="megamenu-mlid-978" class="megamenu-item megamenu-item-41 even half-1 leaf-41 "><a href="/crt-and-astrazeneca-expand-successful-multi-project-cancer-metabolism-alliance">CRT and AstraZeneca expand successful multi-project cancer metabolism alliance</a></li><li id="megamenu-mlid-2861" class="megamenu-item megamenu-item-42 odd half-1 leaf-42 "><a href="/crt-and-bioinvent-expand-collaboration-university-southampton-scientists-develop-new-immunotherapy">CRT and BioInvent expand collaboration with University of Southampton scientists</a></li><li id="megamenu-mlid-1225" class="megamenu-item megamenu-item-43 even half-1 leaf-43 "><a href="/crt-and-tevas-collaboration-yields-successful-outcome">CRT and Teva’s collaboration yields successful outcome with novel aPKC protein inhibitor cancer drug discovery candidate</a></li><li id="megamenu-mlid-979" class="megamenu-item megamenu-item-44 odd half-1 leaf-44 "><a href="/crt-and-icr-enter-collaboration-janssen-discover-multiple-myeloma-drug">CRT and The ICR enter collaboration with Janssen to discover multiple myeloma drug</a></li><li id="megamenu-mlid-5121" class="megamenu-item megamenu-item-45 even half-1 leaf-45 "><a href="/crt-and-university-copenhagen-announce-agreement-adc-therapeutics-develop-antibody-treatments-cancer">CRT and University of Copenhagen announce agreement with ADC Therapeutics to develop antibody treatments for cancer</a></li><li id="megamenu-mlid-5076" class="megamenu-item megamenu-item-46 odd half-1 leaf-46 "><a href="/crt-announces-license-agreement-msd-develop-inhibitors-prmt5-cancer-and-blood-disorders">CRT announces license agreement with MSD to develop inhibitors of PRMT5 for cancer and blood disorders</a></li><li id="megamenu-mlid-1001" class="megamenu-item megamenu-item-47 even half-1 leaf-47 "><a href="/crt-drives-novel-and-collaborative-drug-discovery-areas-%C3%A2%E2%82%AC%C5%93hot%C3%A2%E2%82%AC%C2%9D-cancer-science">CRT drives novel and collaborative drug discovery in areas of &quot;hot&quot; cancer science</a></li><li id="megamenu-mlid-5096" class="megamenu-item megamenu-item-48 odd half-1 leaf-48 "><a href="/crt-signs-agreement-cimass-development-monoclonal-antibody-treatment-cancer">CRT signs agreement with CiMass for the development of a monoclonal antibody in the treatment of cancer.</a></li><li id="megamenu-mlid-977" class="megamenu-item megamenu-item-49 even half-1 leaf-49 "><a href="/crt-unveils-screen-test-potential-drugs-treat-oestrogen-positive-breast-cancer">CRT unveils screen test for potential drugs to treat oestrogen positive breast cancer</a></li><li id="megamenu-mlid-1146" class="megamenu-item megamenu-item-50 odd half-1 leaf-50 "><a href="/crt-university-manchester-and-glaxosmithkline-work-together-generate-new-cancer-drugs">CRT, University of Manchester and GlaxoSmithKline work together to generate new cancer drugs</a></li><li id="megamenu-mlid-1691" class="megamenu-item megamenu-item-51 even half-1 leaf-51 "><a href="/cancer-research-uk-cancer-research-technology-and-asterias-biotherapeutics-partner-trial">CRUK, CRT and Asterias Biotherapeutics partner to trial immunotherapy vaccine for lung cancer</a></li><li id="megamenu-mlid-1621" class="megamenu-item megamenu-item-52 odd half-1 leaf-52 "><a href="/call-small-molecules-tool-compounds">Call for Small Molecules as Tool Compounds</a></li><li id="megamenu-mlid-1606" class="megamenu-item megamenu-item-53 even half-2 leaf-53 "><a href="/cancer-advance-harvard-med">Cancer Advance Harvard Med</a></li><li id="megamenu-mlid-1601" class="megamenu-item megamenu-item-54 odd half-2 leaf-54 "><a href="/cancer-drug-discovery-and-preclinical-development-summit">Cancer Drug Discovery and Preclinical Development Summit</a></li><li id="megamenu-mlid-1611" class="megamenu-item megamenu-item-55 even half-2 leaf-55 "><a href="/cancer-research-technology-and-forma-therapeutics-excellent-marriage">Cancer Research Technology and FORMA Therapeutics: An excellent marriage</a></li><li id="megamenu-mlid-2871" class="megamenu-item megamenu-item-56 odd half-2 leaf-56 "><a href="/cancer-research-technology-and-medivir-collaborate-develop-new-class-cancer-drugs">Cancer Research Technology and Medivir collaborate to develop new class of cancer drugs</a></li><li id="megamenu-mlid-1128" class="megamenu-item megamenu-item-57 even half-2 leaf-57 "><a href="/cancer-research-technology-and-nuevolution-sign-multi-target-deal-seek-potential-cancer-drugs">Cancer Research Technology and Nuevolution sign multi-target deal to seek potential cancer drugs</a></li><li id="megamenu-mlid-6061" class="megamenu-item megamenu-item-58 odd half-2 leaf-58 "><a href="/cancer-research-technology-and-pangaea-biotech-sign-license-agreement-new-cancer-drugs">Cancer Research Technology and Pangaea Biotech sign license agreement for new cancer drugs</a></li><li id="megamenu-mlid-4706" class="megamenu-item megamenu-item-59 even half-2 leaf-59 "><a href="/cancer-research-technology-appoints-deborah-harland-non-executive-director">Cancer Research Technology appoints Deborah Harland as Non-Executive Director</a></li><li id="megamenu-mlid-2536" class="megamenu-item megamenu-item-60 odd half-2 leaf-60 "><a href="/cancer-research-technology-introduces-ximbio-online-reagents-portal">Cancer Research Technology introduces Ximbio, an online reagents portal</a></li><li id="megamenu-mlid-1160" class="megamenu-item megamenu-item-61 even half-2 leaf-61 "><a href="/cancer-research-uk-and-astrazeneca-sign-deal-repurpose-asthma-drug-could-fight-kidney-cancer">Cancer Research UK and AstraZeneca sign deal to repurpose asthma drug that could fight kidney cancer</a></li><li id="megamenu-mlid-3131" class="megamenu-item megamenu-item-62 odd half-2 leaf-62 "><a href="/cancer-research-uk-and-cancer-research-technology-announce-partnership-monopar-therapeutics-develop">Cancer Research UK and Cancer Research Technology announce partnership with Monopar Therapeutics</a></li><li id="megamenu-mlid-1581" class="megamenu-item megamenu-item-63 even half-2 leaf-63 "><a href="/cancer-research-uk-and-cancer-research-technology-join-forces-astellas-autophagy-find-new-cancer">Cancer Research UK and Cancer Research Technology join forces with Astellas on autophagy to find new cancer treatments</a></li><li id="megamenu-mlid-2781" class="megamenu-item megamenu-item-64 odd half-2 leaf-64 "><a href="/cancer-research-uk-and-leukaemia-lymphoma-research-team-boost-blood-cancer-trials">Cancer Research UK and Leukaemia &amp; Lymphoma Research team up to boost blood cancer trials</a></li><li id="megamenu-mlid-1991" class="megamenu-item megamenu-item-65 even half-2 leaf-65 "><a href="/cancer-research-uk-and-medimmune-establish-joint-cruk-medi-alliance-laboratory-develop-new-biologic">Cancer Research UK and MedImmune establish joint CRUK-MEDI Alliance Laboratory to develop new biologic cancer medicines</a></li><li id="megamenu-mlid-3181" class="megamenu-item megamenu-item-66 odd half-2 leaf-66 "><a href="/cancer-research-uk-and-medimmune-launch-ground-breaking-biotherapeutics-research-centre-cambridge">Cancer Research UK and MedImmune launch ground-breaking biotherapeutics research centre in Cambridge</a></li><li id="megamenu-mlid-1223" class="megamenu-item megamenu-item-67 even half-2 leaf-67 "><a href="/cancer-research-uk-drug-launched-its-first-clinical-trial">Cancer Research UK drug launched in its first clinical trial</a></li><li id="megamenu-mlid-2801" class="megamenu-item megamenu-item-68 odd half-2 leaf-68 "><a href="/cancer-research-uk-collaborate-astrazeneca-screening-new-cancer-medicines-astrazeneca-mrc-uk-centre">Cancer Research UK to collaborate with AstraZeneca in screening for new cancer medicines</a></li><li id="megamenu-mlid-2831" class="megamenu-item megamenu-item-69 even half-2 leaf-69 "><a href="/cancer-research-uk-crt-and-amgen-trial-leukaemia-immunotherapy-drug-other-cancers">Cancer Research UK, CRT and Amgen to trial leukaemia immunotherapy drug in other cancers</a></li><li id="megamenu-mlid-2866" class="megamenu-item megamenu-item-70 odd half-2 leaf-70 "><a href="/consortium-signs-deal-basilea-develop-resistance-busting-cancer-drugs">Consortium signs deal with Basilea to develop resistance-busting cancer drugs</a></li><li id="megamenu-mlid-3146" class="megamenu-item megamenu-item-71 even half-2 leaf-71 "><a href="/elrig-drug-discovery-2015">ELRIG Drug Discovery 2015</a></li><li id="megamenu-mlid-1326" class="megamenu-item megamenu-item-72 odd half-2 leaf-72 "><a href="/faseb-lipids-and-lipid-regulated-kinases-cancer">FASEB: Lipids and Lipid Regulated Kinases in Cancer</a></li><li id="megamenu-mlid-5046" class="megamenu-item megamenu-item-73 even half-2 leaf-73 "><a href="/forma-therapeutics-and-crt-form-third-virtual-company-advance-deubiquitination-assets">FORMA Therapeutics and CRT form a third virtual company to advance deubiquitination assets</a></li><li id="megamenu-mlid-2856" class="megamenu-item megamenu-item-74 odd half-2 leaf-74 "><a href="/forma-therapeutics-and-crt-form-two-virtual-companies-advance-deubiquitination-assets">FORMA Therapeutics and CRT form two virtual companies to advance deubiquitination assets</a></li><li id="megamenu-mlid-1138" class="megamenu-item megamenu-item-75 even half-2 leaf-75 "><a href="/highlights-ncri-conference-2013">Highlights from the NCRI Conference 2013</a></li><li id="megamenu-mlid-1135" class="megamenu-item megamenu-item-76 odd half-2 leaf-76 "><a href="/hitgen-announces-collaboration-drug-discovery-university-manchester%E2%80%99s-cancer-research-uk-manchester">HitGen Announces Collaboration in Drug Discovery</a></li><li id="megamenu-mlid-5071" class="megamenu-item megamenu-item-77 even half-2 leaf-77 "><a href="/inivata-completes-%C2%A3315-million-45m-series-fundraising-round">Inivata Completes £31.5 Million ($45M) Series A Fundraising Round</a></li><li id="megamenu-mlid-1701" class="megamenu-item megamenu-item-78 odd half-2 leaf-78 "><a href="/inivata-raises-%C2%A34m-realise-potential-ctdna-analysis-improve-cancer-treatment-through-simple-blood">Inivata Raises £4m to Realise the Potential of ctDNA Analysis to Improve Cancer Treatment Through Simple Blood Tests</a></li><li id="megamenu-mlid-2531" class="megamenu-item megamenu-item-79 even half-2 leaf-79 "><a href="/instinctif-partners-hosts-cancer-research-technology-event-innovative-cancer-diagnostics-and">Instinctif Partners hosts Cancer Research Technology event on innovative cancer diagnostics and treatments</a></li><li id="megamenu-mlid-1167" class="megamenu-item megamenu-item-80 odd half-2 leaf-80 "><a href="/international-deal-screen-potential-cancer-drugs-using-dna-barcodes">International deal to screen potential cancer drugs using DNA &#039;barcodes&#039;</a></li><li id="megamenu-mlid-4741" class="megamenu-item megamenu-item-81 even half-2 leaf-81 "><a href="/major-drug-discovery-feasibility-study-merck-serono">MAJOR DRUG DISCOVERY FEASIBILITY STUDY WITH MERCK SERONO</a></li><li id="megamenu-mlid-5081" class="megamenu-item megamenu-item-82 odd half-2 leaf-82 "><a href="/mission-therapeutics-raises-%C2%A360-million-progress-development-novel-dub-inhibitors-innovative-drug">MISSION Therapeutics raises £60 million to progress development of novel DUB inhibitors from innovative drug platform</a></li><li id="megamenu-mlid-3791" class="megamenu-item megamenu-item-83 even half-2 leaf-83 "><a href="/metastasis">Metastasis Workshop 2015</a></li><li id="megamenu-mlid-1996" class="megamenu-item megamenu-item-84 odd half-2 leaf-84 "><a href="/ncri-cancer-conference-2014">NCRI Cancer Conference 2014</a></li><li id="megamenu-mlid-3156" class="megamenu-item megamenu-item-85 even half-2 leaf-85 "><a href="/ncri-cancer-conference-2015">NCRI Cancer Conference 2015</a></li><li id="megamenu-mlid-6076" class="megamenu-item megamenu-item-86 odd half-2 leaf-86 "><a href="/ncri-cancer-conference-2016">NCRI Cancer Conference 2016</a></li><li id="megamenu-mlid-4701" class="megamenu-item megamenu-item-87 even half-2 leaf-87 "><a href="/nemucore-medical-innovations-options-clinical-stage-aurora-kinase-inhibitor-gsk1070916-crt">Nemucore Medical Innovations Options Clinical-Stage Aurora Kinase Inhibitor GSK1070916 From CRT</a></li><li id="megamenu-mlid-1134" class="megamenu-item megamenu-item-88 odd half-2 leaf-88 "><a href="/networking-top-luncheon">Networking at the Top Luncheon</a></li><li id="megamenu-mlid-4746" class="megamenu-item megamenu-item-89 even half-2 leaf-89 "><a href="/catapult">New collaboration for CAR-T cell immuno-oncology therapy development</a></li><li id="megamenu-mlid-3201" class="megamenu-item megamenu-item-90 odd half-2 leaf-90 "><a href="/new-offices-crt-inc">New offices for CRT Inc.</a></li><li id="megamenu-mlid-1316" class="megamenu-item megamenu-item-91 even half-2 leaf-91 "><a href="/helix-2014">ON Helix 2014</a></li><li id="megamenu-mlid-1591" class="megamenu-item megamenu-item-92 odd half-2 leaf-92 "><a href="/pdx-models-workshop-2014">PDX Models Workshop 2014</a></li><li id="megamenu-mlid-1127" class="megamenu-item megamenu-item-93 even half-2 leaf-93 "><a href="/pdx-workshop">PDX Workshop</a></li><li id="megamenu-mlid-1311" class="megamenu-item megamenu-item-94 odd half-2 leaf-94 "><a href="/preclinical-models-network-taking-shape">Preclinical models network taking shape</a></li><li id="megamenu-mlid-1229" class="megamenu-item megamenu-item-95 even half-2 leaf-95 "><a href="/promising-results-phase-1-trial-lead-immatics-continue-work-vaccine-ima950-glioblastoma">Promising results in Phase 1 trial lead immatics to continue work on vaccine (IMA950) for glioblastoma</a></li><li id="megamenu-mlid-2876" class="megamenu-item megamenu-item-96 odd half-2 leaf-96 "><a href="/rd-alliance-restructure-presents-new-dna-damage-response-partnership-opportunities-including-leading">R&amp;D alliance restructure presents new DNA damage response partnership opportunities including leading PolQ project</a></li><li id="megamenu-mlid-3171" class="megamenu-item megamenu-item-97 even half-2 leaf-97 "><a href="/Sachs">Sachs 15th Annual Biotech in Europe Forum</a></li><li id="megamenu-mlid-6381" class="megamenu-item megamenu-item-98 odd half-2 leaf-98 "><a href="/storm-therapeutics-secures-%C2%A312m-investment-cancer-therapeutics">Storm Therapeutics secures £12m investment for cancer therapeutics</a></li><li id="megamenu-mlid-1222" class="megamenu-item megamenu-item-99 even half-2 leaf-99 "><a href="/successful-completion-phase-i-trial-gsk1070916">Successful completion of the Phase I trial of GSK1070916</a></li><li id="megamenu-mlid-2811" class="megamenu-item megamenu-item-100 odd half-2 leaf-100 "><a href="/three-new-companies-join-cancer-research-uk-abcodia-collaboration-identify-blood-markers-early">Three new companies join Cancer Research UK-Abcodia collaboration to identify blood markers for early cancer detection</a></li><li id="megamenu-mlid-1696" class="megamenu-item megamenu-item-101 even half-2 leaf-101 "><a href="/two-cancer-research-technology-deals-shortlisted-leading-industry-awards">Two Cancer Research Technology deals shortlisted for leading industry awards</a></li><li id="megamenu-mlid-2851" class="megamenu-item megamenu-item-102 odd half-2 leaf-102 "><a href="/valneva-and-blink-therapeutics-confirm-launch-and-funding-blink-biomedical">Valneva and BliNK Therapeutics confirm launch and funding of BliNK Biomedical</a></li><li id="megamenu-mlid-1321" class="megamenu-item megamenu-item-103 even half-2 leaf-103 "><a href="/world-pharma-licensing-congress-2014">World Pharma Licensing Congress 2014</a></li><li id="megamenu-mlid-2791" class="megamenu-item megamenu-item-104 odd half-2 leaf-104 last last"><a href="/%C2%A350m-crt-pioneer-fund-announces-investment-develop-lung-cancer-drugs-cancer-research-uks-manchester">£50M CRT Pioneer Fund announces invest to develop lung cancer drugs at Cancer Research UK&#039;s Manchester Institute</a></li></ul></li><li id="megamenu-mlid-837" class="megamenu-slot megamenu-slot-1 even half-2 leaf-1 last last"><span class="megamenu-slot-title"><a href="/cruk-science">CRUK Science</a></span></li></ul></li><li id="megamenu-mlid-861" class="megamenu-parent menuitem megamenu-parent-6 odd half-2 leaf-6 menu-861 "><a href="/careers">Careers</a><span class="arrow"></span><span class="highlight"></span><ul class="submenu megamenu-bin megamenu-slots-columnar"><li id="megamenu-mlid-862" class="megamenu-slot megamenu-slot-0 odd half-1 leaf-0 first first"><span class="megamenu-slot-title"><a href="/careers">Careers</a></span></li><li id="megamenu-mlid-832" class="megamenu-slot megamenu-slot-1 even half-2 leaf-1 last last"><span class="megamenu-slot-title"><a href="/vacancies">Vacancies</a></span></li></ul></li><li id="megamenu-mlid-838" class="megamenu-parent menuitem megamenu-parent-7 even half-2 leaf-7 last menu-838 last"><a href="/contact-us">Contact Us</a><span class="arrow"></span><span class="highlight"></span><ul class="submenu megamenu-bin megamenu-slots-columnar"><li id="megamenu-mlid-940" class="megamenu-slot megamenu-slot-0 odd half-1 leaf-0 first first last"><span class="megamenu-slot-title"><a href="/contact-us">Contact Us</a></span></li></ul></li></ul> </nav> 
<script>
$(document).ready(function(){
$('#navbar').find('#megamenu-main-menu').addClass('nav navbar-nav');
$('#navbar').find('.megamenu-parent').addClass('dropdown');
// Go directly to link
$('#navbar').find('.megamenu-parent.first, .megamenu-parent#megamenu-mlid-825, .megamenu-parent#megamenu-mlid-838').on('click', function(){
window.location = $(this).find('a').attr('href');
});
// This adds the needed classes to have Bootstrap expand this menu parent
$('#navbar').find('.megamenu-parent > a').addClass('dropdown-toggle')
.attr('data-toggle', 'dropdown')
.attr('role', 'button')
.attr('aria-haspopup', 'true')
.attr('aria-expanded', 'false');
$('#navbar').find('.megamenu-parent ul.submenu').addClass('dropdown-menu');
// $('#navbar').find('.megamenu-parent ul.submenu li.megamenu-slot > ul.megamenu-items').addClass('dropdown-menu');
// Site search
$('.search-icon').on('click', function(e){
e.preventDefault();
$('.mobile-search').slideToggle('mobile-search-hidden');
$('.search-form').find('.custom-search-box').attr('placeholder', 'Start typing search...').focus();
$(this).toggleClass('dimmed');
});
if ($('body').hasClass('page-search')) {
$('.mobile-search').toggleClass('mobile-search-hidden');
}
// Fix for licensing opportunties page
$('.page-node-1041 .template1 .contentContainer .block-content2').append( $('#sidebar-first .menu .expanded .menu') );
});
</script>
<nav role="navigation" class="navbar navbar-default visible-xs-block mobile-menu"><div class="navbar-header"> <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#navbar" aria-expanded="false" aria-controls="navbar"> <span class="sr-only">Toggle navigation</span> <span class="icon-bar"></span> <span class="icon-bar"></span> <span class="icon-bar"></span> </button> <a class="navbar-brand" href="/">CRT</a> <a class="search-icon" href="/">SEARCH</a></div><div class="mobile-search mobile-search-hidden hidden-md"><form class="search-form" role="search" onsubmit="if(this.search_block_form.value==&#039;Site search&#039;){ alert(&#039;Please enter a search&#039;); return false; }" action="/" method="post" id="search-block-form" accept-charset="UTF-8"><div><div class="container-inline"><h2 class="element-invisible">Search form</h2><div class="form-item form-type-textfield form-item-search-block-form"> <label class="element-invisible" for="edit-search-block-form--2">Search </label> <input title="Enter the terms you wish to search for." class="custom-search-box form-text" placeholder="Site search" onblur="if (this.value == &#039;&#039;) {this.value = &#039;Site search&#039;;}" onfocus="if (this.value == &#039;Site search&#039;) {this.value = &#039;&#039;;}" type="text" id="edit-search-block-form--2" name="search_block_form" value="Site search" size="40" maxlength="128" /></div><div class="form-actions form-wrapper" id="edit-actions"><input type="submit" id="edit-submit" name="op" value="" class="form-submit" /></div><input type="hidden" name="form_build_id" value="form-_MB4V_bJ6tdniWd-DMDFoi87cEsuq4VSh38fQrNTAxA" /><input type="hidden" name="form_id" value="search_block_form" /></div></div></form></div><div id="navbar" class="navbar-collapse collapse"><ul id="megamenu-main-menu" class="megamenu-menu columnar megamenu-skin-friendly"><li id="megamenu-mlid-218" class="megamenu-parent menuitem megamenu-parent-0 odd half-1 leaf-0 first menu-218 first"><a href="/" class="active">Home</a><span class="arrow"></span><span class="highlight"></span></li><li id="megamenu-mlid-942" class="megamenu-parent menuitem megamenu-parent-1 even half-1 leaf-1 menu-942 "><a href="/our-company">About CRT</a><span class="arrow"></span><span class="highlight"></span><ul class="submenu megamenu-bin megamenu-slots-columnar"><li id="megamenu-mlid-943" class="megamenu-slot megamenu-slot-0 odd half-1 leaf-0 first first"><span class="megamenu-slot-title"><a href="/our-company">Our Company</a></span></li><li id="megamenu-mlid-828" class="megamenu-slot megamenu-slot-1 even half-1 leaf-1 "><span class="megamenu-slot-title"><a href="/our-people">Our People</a></span></li><li id="megamenu-mlid-839" class="megamenu-slot megamenu-slot-2 odd half-2 leaf-2 "><span class="megamenu-slot-title"><a href="/our-network">Our Network</a></span></li><li id="megamenu-mlid-827" class="megamenu-slot megamenu-slot-3 even half-2 leaf-3 last last"><span class="megamenu-slot-title"><a href="/our-history">Our History</a></span></li></ul></li><li id="megamenu-mlid-835" class="megamenu-parent menuitem megamenu-parent-2 odd half-1 leaf-2 menu-835 "><a href="/services">Services</a><span class="arrow"></span><span class="highlight"></span><ul class="submenu megamenu-bin megamenu-slots-columnar"><li id="megamenu-mlid-841" class="megamenu-slot megamenu-slot-0 odd half-1 leaf-0 first first"><span class="megamenu-slot-title"><a href="/services">Overview</a></span></li><li id="megamenu-mlid-831" class="megamenu-slot megamenu-slot-1 even half-1 leaf-1 "><span class="megamenu-slot-title"><a href="/project-development">Project Development</a></span><ul class="megamenu-items "><li id="megamenu-mlid-842" class="megamenu-item megamenu-item-0 odd half-1 leaf-0 first first last"><a href="/have-idea">Have an idea?</a></li></ul></li><li id="megamenu-mlid-845" class="megamenu-slot megamenu-slot-2 odd half-1 leaf-2 "><span class="megamenu-slot-title"><a href="/commercialisation">Commercialisation</a></span></li><li id="megamenu-mlid-847" class="megamenu-slot megamenu-slot-3 even half-1 leaf-3 "><span class="megamenu-slot-title"><a href="/drug-discovery">Drug Discovery</a></span><ul class="megamenu-items "><li id="megamenu-mlid-1047" class="megamenu-item megamenu-item-0 odd half-1 leaf-0 first first last"><a href="/cruk-drug-discovery">CRUK Drug Discovery</a></li></ul></li><li id="megamenu-mlid-851" class="megamenu-slot megamenu-slot-4 odd half-2 leaf-4 "><span class="megamenu-slot-title"><a href="/clinical-development">Clinical Development</a></span><ul class="megamenu-items "><li id="megamenu-mlid-826" class="megamenu-item megamenu-item-0 odd half-1 leaf-0 first first last"><a href="/cdp">CDP</a></li></ul></li><li id="megamenu-mlid-818" class="megamenu-slot megamenu-slot-5 even half-2 leaf-5 "><span class="megamenu-slot-title"><a href="/imaging">Imaging</a></span></li><li id="megamenu-mlid-976" class="megamenu-slot megamenu-slot-6 odd half-2 leaf-6 last last"><span class="megamenu-slot-title"><a href="/funding">Funding</a></span></li></ul></li><li id="megamenu-mlid-836" class="megamenu-parent menuitem megamenu-parent-3 even half-1 leaf-3 menu-836 "><a href="/our-projects">Projects</a><span class="arrow"></span><span class="highlight"></span><ul class="submenu megamenu-bin megamenu-slots-columnar"><li id="megamenu-mlid-852" class="megamenu-slot megamenu-slot-0 odd half-1 leaf-0 first first"><span class="megamenu-slot-title"><a href="/our-projects">Overview</a></span></li><li id="megamenu-mlid-829" class="megamenu-slot megamenu-slot-1 even half-1 leaf-1 "><span class="megamenu-slot-title"><a href="/our-pipeline">Our Pipeline</a></span></li><li id="megamenu-mlid-819" class="megamenu-slot megamenu-slot-2 odd half-2 leaf-2 "><span class="megamenu-slot-title"><a href="/licensing-opportunities">Licensing Opportunities</a></span><ul class="megamenu-items "><li id="megamenu-mlid-1036" class="megamenu-item megamenu-item-0 odd half-1 leaf-0 first first"><a href="/lo-small-molecules-search">Small Molecules</a></li><li id="megamenu-mlid-1038" class="megamenu-item megamenu-item-1 even half-1 leaf-1 "><a href="/lo-biological-therapeutics-search">Biological Therapeutics</a></li><li id="megamenu-mlid-1039" class="megamenu-item megamenu-item-2 odd half-1 leaf-2 "><a href="/lo-enabling-technology-search">Enabling Technology</a></li><li id="megamenu-mlid-1042" class="megamenu-item megamenu-item-3 even half-2 leaf-3 "><a href="/lo-medical-devices-search">Medical Devices</a></li><li id="megamenu-mlid-1044" class="megamenu-item megamenu-item-4 odd half-2 leaf-4 last last"><a href="/lo-biomarkers-search">Biomarkers</a></li></ul></li><li id="megamenu-mlid-830" class="megamenu-slot megamenu-slot-3 even half-2 leaf-3 last last"><span class="megamenu-slot-title"><a href="/our-start-ups">Our Start-ups</a></span></li></ul></li><li id="megamenu-mlid-825" class="megamenu-parent menuitem megamenu-parent-4 odd half-2 leaf-4 menu-825 "><a href="/research-tools">Research Tools</a><span class="arrow"></span><span class="highlight"></span><ul class="submenu megamenu-bin megamenu-slots-columnar"><li id="megamenu-mlid-858" class="megamenu-slot megamenu-slot-0 odd half-1 leaf-0 first first last"><span class="megamenu-slot-title"><a href="/research-tools">Research Tools</a></span></li></ul></li><li id="megamenu-mlid-860" class="megamenu-parent menuitem megamenu-parent-5 even half-2 leaf-5 menu-860 "><a href="/news-and-events">News and Events</a><span class="arrow"></span><span class="highlight"></span><ul class="submenu megamenu-bin megamenu-slots-columnar"><li id="megamenu-mlid-816" class="megamenu-slot megamenu-slot-0 odd half-1 leaf-0 first first"><span class="megamenu-slot-title"><a href="/news-and-events">News and Events</a></span><ul class="megamenu-items "><li id="megamenu-mlid-933" class="megamenu-item megamenu-item-0 odd half-1 leaf-0 first first"><a href="/alliance-translational-research-centres-established-accelerate-global-drug-development">Alliance of translational research centres established to accelerate global drug development</a></li><li id="megamenu-mlid-935" class="megamenu-item megamenu-item-1 even half-1 leaf-1 "><a href="/astex-pharmaceuticals-earns-54-m-milestone-phi-trial-initiation-fgfr-kinase-inhibitor">Astex Pharmaceuticals Earns $5.4 M Milestone on PhI Trial Initiation of a FGFR Kinase Inhibitor</a></li><li id="megamenu-mlid-934" class="megamenu-item megamenu-item-2 odd half-1 leaf-2 "><a href="/crt-adc-therapeutics-join-forces-antibody-drug-conjugates">CRT &amp; ADC Therapeutics join forces on Antibody Drug Conjugates</a></li><li id="megamenu-mlid-915" class="megamenu-item megamenu-item-3 even half-1 leaf-3 "><a href="/crt-and-teva-pharmaceuticals-form-rd-alliance-cancer-dna-damage-response-drugs">CRT and Teva Pharmaceuticals Form R&amp;D Alliance for Cancer DNA Damage Response Drugs</a></li><li id="megamenu-mlid-916" class="megamenu-item megamenu-item-4 odd half-1 leaf-4 "><a href="/crt-institute-cancer-research-and-merck-serono-sign-wnt-licensing-deal-0">CRT, The Institute of Cancer Research and Merck Serono sign WNT licensing deal</a></li><li id="megamenu-mlid-873" class="megamenu-item megamenu-item-5 even half-1 leaf-5 "><a href="/cruk-cambridge-institute-symposium">CRUK Cambridge Institute Symposium</a></li><li id="megamenu-mlid-937" class="megamenu-item megamenu-item-6 odd half-1 leaf-6 "><a href="/cancer-research-uk-and-crt-collaborate-abcodia-discover-and-develop-tests-cancer-1">Cancer Research UK and CRT collaborate with Abcodia to discover and develop tests for cancer</a></li><li id="megamenu-mlid-917" class="megamenu-item megamenu-item-7 even half-1 leaf-7 "><a href="/forma-therapeutics-and-crt-discover-cancer-drugs-targeting-deubiquitinating-enzymes-dubs">FORMA Therapeutics and CRT to discover cancer drugs targeting deubiquitinating enzymes (DUBs)</a></li><li id="megamenu-mlid-936" class="megamenu-item megamenu-item-8 odd half-1 leaf-8 "><a href="/new-board-appointment-crt">New board appointment for CRT</a></li><li id="megamenu-mlid-864" class="megamenu-item megamenu-item-9 even half-1 leaf-9 "><a href="/new-offices-crt">New offices for CRT</a></li><li id="megamenu-mlid-1616" class="megamenu-item megamenu-item-10 odd half-1 leaf-10 "><a href="/cruk-research-strategy-great-place-come-and-do-business">&quot;This is a great place to come and do business&quot;</a></li><li id="megamenu-mlid-1228" class="megamenu-item megamenu-item-11 even half-1 leaf-11 "><a href="/2014-bio-international-convention">2014 BIO International Convention</a></li><li id="megamenu-mlid-1331" class="megamenu-item megamenu-item-12 odd half-1 leaf-12 "><a href="/2014-medicinal-chemistry-gordon-research-conference">2014 Medicinal Chemistry Gordon Research Conference</a></li><li id="megamenu-mlid-2816" class="megamenu-item megamenu-item-13 even half-1 leaf-13 "><a href="/2014-year-review-infographic">2014 Year in Review Infographic</a></li><li id="megamenu-mlid-3126" class="megamenu-item megamenu-item-14 odd half-1 leaf-14 "><a href="/2015-bio-international-convention">2015 BIO International Convention</a></li><li id="megamenu-mlid-5451" class="megamenu-item megamenu-item-15 even half-1 leaf-15 "><a href="/2016-bio-international-convention">2016 BIO International Convention</a></li><li id="megamenu-mlid-1596" class="megamenu-item megamenu-item-16 odd half-1 leaf-16 "><a href="/26th-eortc-nci-aacr-symposium">26th EORTC-NCI-AACR SYMPOSIUM</a></li><li id="megamenu-mlid-1224" class="megamenu-item megamenu-item-17 even half-1 leaf-17 "><a href="/aacr-annual-meeting-2014">AACR Annual Meeting</a></li><li id="megamenu-mlid-2846" class="megamenu-item megamenu-item-18 odd half-1 leaf-18 "><a href="/aacr-annual-meeting-2015">AACR Annual Meeting 2015</a></li><li id="megamenu-mlid-4716" class="megamenu-item megamenu-item-19 even half-1 leaf-19 "><a href="/AACR2016">AACR Annual Meeting 2016</a></li><li id="megamenu-mlid-3166" class="megamenu-item megamenu-item-20 odd half-1 leaf-20 "><a href="/aacr-nci-eortc">AACR-NCI-EORTC 2015</a></li><li id="megamenu-mlid-2836" class="megamenu-item megamenu-item-21 even half-1 leaf-21 "><a href="/autm-2015-annual-meeting">AUTM 2015 Annual Meeting</a></li><li id="megamenu-mlid-4711" class="megamenu-item megamenu-item-22 odd half-1 leaf-22 "><a href="/AUTM2016">AUTM 2016 Annual Meeting</a></li><li id="megamenu-mlid-2826" class="megamenu-item megamenu-item-23 even half-1 leaf-23 "><a href="/academic-drug-discovery-workshop">Academic Drug Discovery Workshop</a></li><li id="megamenu-mlid-3796" class="megamenu-item megamenu-item-24 odd half-1 leaf-24 "><a href="/StructuralBiology2016">Accelerator Structural Biology Conference 2016</a></li><li id="megamenu-mlid-1195" class="megamenu-item megamenu-item-25 even half-1 leaf-25 "><a href="/alchemia-announces-licensing-fak-inhibitors-crt">Alchemia announces in-licensing of FAK inhibitors from CRT</a></li><li id="megamenu-mlid-2796" class="megamenu-item megamenu-item-26 odd half-1 leaf-26 "><a href="/bacit-seeks-shareholder-approval-commit-%C2%A320m-and-join-crt-pioneer-fund-limited-partner">BACIT seeks shareholder approval to commit £20m and join CRT Pioneer Fund as a limited partner</a></li><li id="megamenu-mlid-4721" class="megamenu-item megamenu-item-27 even half-1 leaf-27 "><a href="/BioSpring2016">BIO-EUROPE SPRING 2016</a></li><li id="megamenu-mlid-1192" class="megamenu-item megamenu-item-28 odd half-1 leaf-28 "><a href="/bio-europe-spring-2014">BIO-Europe Spring 2014</a></li><li id="megamenu-mlid-3161" class="megamenu-item megamenu-item-29 even half-1 leaf-29 "><a href="/bio-europe-autumn-2015">Bio-Europe 2015</a></li><li id="megamenu-mlid-6071" class="megamenu-item megamenu-item-30 odd half-1 leaf-30 "><a href="/bio-europe-autumn-2016">Bio-Europe Autumn 2016</a></li><li id="megamenu-mlid-6706" class="megamenu-item megamenu-item-31 even half-1 leaf-31 "><a href="/bio-homecoming-2016">Bio-Homecoming 2016</a></li><li id="megamenu-mlid-2841" class="megamenu-item megamenu-item-32 odd half-1 leaf-32 "><a href="/bioinvents-bi-1206-antibody-enter-collaborative-trial">BioInvents BI-1206 antibody to enter collaborative Phase I/II trial</a></li><li id="megamenu-mlid-3121" class="megamenu-item megamenu-item-33 even half-1 leaf-33 "><a href="/biowednesday-future-directions-oncology">BioWednesday: Future Directions in Oncology</a></li><li id="megamenu-mlid-2806" class="megamenu-item megamenu-item-34 odd half-1 leaf-34 "><a href="/biotech-and-money-london-2015">Biotech and Money London 2015</a></li><li id="megamenu-mlid-1656" class="megamenu-item megamenu-item-35 even half-1 leaf-35 "><a href="/biotechs-and-city">Biotechs and the City</a></li><li id="megamenu-mlid-3136" class="megamenu-item megamenu-item-36 odd half-1 leaf-36 "><a href="/crt-highlighted-dowling-review-business-university-research-collaborations">CRT Highlighted in the Dowling Review of Business-University Research Collaborations</a></li><li id="megamenu-mlid-2821" class="megamenu-item megamenu-item-37 even half-1 leaf-37 "><a href="/crt-pioneer-fund-banks-%C2%A320m-investment-bacit-and-expands-agreement-chroma-therapeutics-develop">CRT Pioneer Fund banks £20m investment from BACIT and expands agreement with Chroma Therapeutics</a></li><li id="megamenu-mlid-1126" class="megamenu-item megamenu-item-38 odd half-1 leaf-38 "><a href="/crt-pioneer-fund-collaborates-chroma-therapeutics-develop-cancer-drugs-targeting-immune-system">CRT Pioneer Fund collaborates with Chroma Therapeutics</a></li><li id="megamenu-mlid-1045" class="megamenu-item megamenu-item-39 even half-1 leaf-39 "><a href="/crt-pioneer-fund-bacit-and-sareum-enter-agreement-fund-development-drugs-treat-cancers-including">CRT Pioneer Fund, BACIT and Sareum enter agreement</a></li><li id="megamenu-mlid-6386" class="megamenu-item megamenu-item-40 odd half-1 leaf-40 "><a href="/crt-and-alta-innovations-join-forces-commercialise-world-leading-research">CRT and Alta Innovations join forces to commercialise world-leading research</a></li><li id="megamenu-mlid-978" class="megamenu-item megamenu-item-41 even half-1 leaf-41 "><a href="/crt-and-astrazeneca-expand-successful-multi-project-cancer-metabolism-alliance">CRT and AstraZeneca expand successful multi-project cancer metabolism alliance</a></li><li id="megamenu-mlid-2861" class="megamenu-item megamenu-item-42 odd half-1 leaf-42 "><a href="/crt-and-bioinvent-expand-collaboration-university-southampton-scientists-develop-new-immunotherapy">CRT and BioInvent expand collaboration with University of Southampton scientists</a></li><li id="megamenu-mlid-1225" class="megamenu-item megamenu-item-43 even half-1 leaf-43 "><a href="/crt-and-tevas-collaboration-yields-successful-outcome">CRT and Teva’s collaboration yields successful outcome with novel aPKC protein inhibitor cancer drug discovery candidate</a></li><li id="megamenu-mlid-979" class="megamenu-item megamenu-item-44 odd half-1 leaf-44 "><a href="/crt-and-icr-enter-collaboration-janssen-discover-multiple-myeloma-drug">CRT and The ICR enter collaboration with Janssen to discover multiple myeloma drug</a></li><li id="megamenu-mlid-5121" class="megamenu-item megamenu-item-45 even half-1 leaf-45 "><a href="/crt-and-university-copenhagen-announce-agreement-adc-therapeutics-develop-antibody-treatments-cancer">CRT and University of Copenhagen announce agreement with ADC Therapeutics to develop antibody treatments for cancer</a></li><li id="megamenu-mlid-5076" class="megamenu-item megamenu-item-46 odd half-1 leaf-46 "><a href="/crt-announces-license-agreement-msd-develop-inhibitors-prmt5-cancer-and-blood-disorders">CRT announces license agreement with MSD to develop inhibitors of PRMT5 for cancer and blood disorders</a></li><li id="megamenu-mlid-1001" class="megamenu-item megamenu-item-47 even half-1 leaf-47 "><a href="/crt-drives-novel-and-collaborative-drug-discovery-areas-%C3%A2%E2%82%AC%C5%93hot%C3%A2%E2%82%AC%C2%9D-cancer-science">CRT drives novel and collaborative drug discovery in areas of &quot;hot&quot; cancer science</a></li><li id="megamenu-mlid-5096" class="megamenu-item megamenu-item-48 odd half-1 leaf-48 "><a href="/crt-signs-agreement-cimass-development-monoclonal-antibody-treatment-cancer">CRT signs agreement with CiMass for the development of a monoclonal antibody in the treatment of cancer.</a></li><li id="megamenu-mlid-977" class="megamenu-item megamenu-item-49 even half-1 leaf-49 "><a href="/crt-unveils-screen-test-potential-drugs-treat-oestrogen-positive-breast-cancer">CRT unveils screen test for potential drugs to treat oestrogen positive breast cancer</a></li><li id="megamenu-mlid-1146" class="megamenu-item megamenu-item-50 odd half-1 leaf-50 "><a href="/crt-university-manchester-and-glaxosmithkline-work-together-generate-new-cancer-drugs">CRT, University of Manchester and GlaxoSmithKline work together to generate new cancer drugs</a></li><li id="megamenu-mlid-1691" class="megamenu-item megamenu-item-51 even half-1 leaf-51 "><a href="/cancer-research-uk-cancer-research-technology-and-asterias-biotherapeutics-partner-trial">CRUK, CRT and Asterias Biotherapeutics partner to trial immunotherapy vaccine for lung cancer</a></li><li id="megamenu-mlid-1621" class="megamenu-item megamenu-item-52 odd half-1 leaf-52 "><a href="/call-small-molecules-tool-compounds">Call for Small Molecules as Tool Compounds</a></li><li id="megamenu-mlid-1606" class="megamenu-item megamenu-item-53 even half-2 leaf-53 "><a href="/cancer-advance-harvard-med">Cancer Advance Harvard Med</a></li><li id="megamenu-mlid-1601" class="megamenu-item megamenu-item-54 odd half-2 leaf-54 "><a href="/cancer-drug-discovery-and-preclinical-development-summit">Cancer Drug Discovery and Preclinical Development Summit</a></li><li id="megamenu-mlid-1611" class="megamenu-item megamenu-item-55 even half-2 leaf-55 "><a href="/cancer-research-technology-and-forma-therapeutics-excellent-marriage">Cancer Research Technology and FORMA Therapeutics: An excellent marriage</a></li><li id="megamenu-mlid-2871" class="megamenu-item megamenu-item-56 odd half-2 leaf-56 "><a href="/cancer-research-technology-and-medivir-collaborate-develop-new-class-cancer-drugs">Cancer Research Technology and Medivir collaborate to develop new class of cancer drugs</a></li><li id="megamenu-mlid-1128" class="megamenu-item megamenu-item-57 even half-2 leaf-57 "><a href="/cancer-research-technology-and-nuevolution-sign-multi-target-deal-seek-potential-cancer-drugs">Cancer Research Technology and Nuevolution sign multi-target deal to seek potential cancer drugs</a></li><li id="megamenu-mlid-6061" class="megamenu-item megamenu-item-58 odd half-2 leaf-58 "><a href="/cancer-research-technology-and-pangaea-biotech-sign-license-agreement-new-cancer-drugs">Cancer Research Technology and Pangaea Biotech sign license agreement for new cancer drugs</a></li><li id="megamenu-mlid-4706" class="megamenu-item megamenu-item-59 even half-2 leaf-59 "><a href="/cancer-research-technology-appoints-deborah-harland-non-executive-director">Cancer Research Technology appoints Deborah Harland as Non-Executive Director</a></li><li id="megamenu-mlid-2536" class="megamenu-item megamenu-item-60 odd half-2 leaf-60 "><a href="/cancer-research-technology-introduces-ximbio-online-reagents-portal">Cancer Research Technology introduces Ximbio, an online reagents portal</a></li><li id="megamenu-mlid-1160" class="megamenu-item megamenu-item-61 even half-2 leaf-61 "><a href="/cancer-research-uk-and-astrazeneca-sign-deal-repurpose-asthma-drug-could-fight-kidney-cancer">Cancer Research UK and AstraZeneca sign deal to repurpose asthma drug that could fight kidney cancer</a></li><li id="megamenu-mlid-3131" class="megamenu-item megamenu-item-62 odd half-2 leaf-62 "><a href="/cancer-research-uk-and-cancer-research-technology-announce-partnership-monopar-therapeutics-develop">Cancer Research UK and Cancer Research Technology announce partnership with Monopar Therapeutics</a></li><li id="megamenu-mlid-1581" class="megamenu-item megamenu-item-63 even half-2 leaf-63 "><a href="/cancer-research-uk-and-cancer-research-technology-join-forces-astellas-autophagy-find-new-cancer">Cancer Research UK and Cancer Research Technology join forces with Astellas on autophagy to find new cancer treatments</a></li><li id="megamenu-mlid-2781" class="megamenu-item megamenu-item-64 odd half-2 leaf-64 "><a href="/cancer-research-uk-and-leukaemia-lymphoma-research-team-boost-blood-cancer-trials">Cancer Research UK and Leukaemia &amp; Lymphoma Research team up to boost blood cancer trials</a></li><li id="megamenu-mlid-1991" class="megamenu-item megamenu-item-65 even half-2 leaf-65 "><a href="/cancer-research-uk-and-medimmune-establish-joint-cruk-medi-alliance-laboratory-develop-new-biologic">Cancer Research UK and MedImmune establish joint CRUK-MEDI Alliance Laboratory to develop new biologic cancer medicines</a></li><li id="megamenu-mlid-3181" class="megamenu-item megamenu-item-66 odd half-2 leaf-66 "><a href="/cancer-research-uk-and-medimmune-launch-ground-breaking-biotherapeutics-research-centre-cambridge">Cancer Research UK and MedImmune launch ground-breaking biotherapeutics research centre in Cambridge</a></li><li id="megamenu-mlid-1223" class="megamenu-item megamenu-item-67 even half-2 leaf-67 "><a href="/cancer-research-uk-drug-launched-its-first-clinical-trial">Cancer Research UK drug launched in its first clinical trial</a></li><li id="megamenu-mlid-2801" class="megamenu-item megamenu-item-68 odd half-2 leaf-68 "><a href="/cancer-research-uk-collaborate-astrazeneca-screening-new-cancer-medicines-astrazeneca-mrc-uk-centre">Cancer Research UK to collaborate with AstraZeneca in screening for new cancer medicines</a></li><li id="megamenu-mlid-2831" class="megamenu-item megamenu-item-69 even half-2 leaf-69 "><a href="/cancer-research-uk-crt-and-amgen-trial-leukaemia-immunotherapy-drug-other-cancers">Cancer Research UK, CRT and Amgen to trial leukaemia immunotherapy drug in other cancers</a></li><li id="megamenu-mlid-2866" class="megamenu-item megamenu-item-70 odd half-2 leaf-70 "><a href="/consortium-signs-deal-basilea-develop-resistance-busting-cancer-drugs">Consortium signs deal with Basilea to develop resistance-busting cancer drugs</a></li><li id="megamenu-mlid-3146" class="megamenu-item megamenu-item-71 even half-2 leaf-71 "><a href="/elrig-drug-discovery-2015">ELRIG Drug Discovery 2015</a></li><li id="megamenu-mlid-1326" class="megamenu-item megamenu-item-72 odd half-2 leaf-72 "><a href="/faseb-lipids-and-lipid-regulated-kinases-cancer">FASEB: Lipids and Lipid Regulated Kinases in Cancer</a></li><li id="megamenu-mlid-5046" class="megamenu-item megamenu-item-73 even half-2 leaf-73 "><a href="/forma-therapeutics-and-crt-form-third-virtual-company-advance-deubiquitination-assets">FORMA Therapeutics and CRT form a third virtual company to advance deubiquitination assets</a></li><li id="megamenu-mlid-2856" class="megamenu-item megamenu-item-74 odd half-2 leaf-74 "><a href="/forma-therapeutics-and-crt-form-two-virtual-companies-advance-deubiquitination-assets">FORMA Therapeutics and CRT form two virtual companies to advance deubiquitination assets</a></li><li id="megamenu-mlid-1138" class="megamenu-item megamenu-item-75 even half-2 leaf-75 "><a href="/highlights-ncri-conference-2013">Highlights from the NCRI Conference 2013</a></li><li id="megamenu-mlid-1135" class="megamenu-item megamenu-item-76 odd half-2 leaf-76 "><a href="/hitgen-announces-collaboration-drug-discovery-university-manchester%E2%80%99s-cancer-research-uk-manchester">HitGen Announces Collaboration in Drug Discovery</a></li><li id="megamenu-mlid-5071" class="megamenu-item megamenu-item-77 even half-2 leaf-77 "><a href="/inivata-completes-%C2%A3315-million-45m-series-fundraising-round">Inivata Completes £31.5 Million ($45M) Series A Fundraising Round</a></li><li id="megamenu-mlid-1701" class="megamenu-item megamenu-item-78 odd half-2 leaf-78 "><a href="/inivata-raises-%C2%A34m-realise-potential-ctdna-analysis-improve-cancer-treatment-through-simple-blood">Inivata Raises £4m to Realise the Potential of ctDNA Analysis to Improve Cancer Treatment Through Simple Blood Tests</a></li><li id="megamenu-mlid-2531" class="megamenu-item megamenu-item-79 even half-2 leaf-79 "><a href="/instinctif-partners-hosts-cancer-research-technology-event-innovative-cancer-diagnostics-and">Instinctif Partners hosts Cancer Research Technology event on innovative cancer diagnostics and treatments</a></li><li id="megamenu-mlid-1167" class="megamenu-item megamenu-item-80 odd half-2 leaf-80 "><a href="/international-deal-screen-potential-cancer-drugs-using-dna-barcodes">International deal to screen potential cancer drugs using DNA &#039;barcodes&#039;</a></li><li id="megamenu-mlid-4741" class="megamenu-item megamenu-item-81 even half-2 leaf-81 "><a href="/major-drug-discovery-feasibility-study-merck-serono">MAJOR DRUG DISCOVERY FEASIBILITY STUDY WITH MERCK SERONO</a></li><li id="megamenu-mlid-5081" class="megamenu-item megamenu-item-82 odd half-2 leaf-82 "><a href="/mission-therapeutics-raises-%C2%A360-million-progress-development-novel-dub-inhibitors-innovative-drug">MISSION Therapeutics raises £60 million to progress development of novel DUB inhibitors from innovative drug platform</a></li><li id="megamenu-mlid-3791" class="megamenu-item megamenu-item-83 even half-2 leaf-83 "><a href="/metastasis">Metastasis Workshop 2015</a></li><li id="megamenu-mlid-1996" class="megamenu-item megamenu-item-84 odd half-2 leaf-84 "><a href="/ncri-cancer-conference-2014">NCRI Cancer Conference 2014</a></li><li id="megamenu-mlid-3156" class="megamenu-item megamenu-item-85 even half-2 leaf-85 "><a href="/ncri-cancer-conference-2015">NCRI Cancer Conference 2015</a></li><li id="megamenu-mlid-6076" class="megamenu-item megamenu-item-86 odd half-2 leaf-86 "><a href="/ncri-cancer-conference-2016">NCRI Cancer Conference 2016</a></li><li id="megamenu-mlid-4701" class="megamenu-item megamenu-item-87 even half-2 leaf-87 "><a href="/nemucore-medical-innovations-options-clinical-stage-aurora-kinase-inhibitor-gsk1070916-crt">Nemucore Medical Innovations Options Clinical-Stage Aurora Kinase Inhibitor GSK1070916 From CRT</a></li><li id="megamenu-mlid-1134" class="megamenu-item megamenu-item-88 odd half-2 leaf-88 "><a href="/networking-top-luncheon">Networking at the Top Luncheon</a></li><li id="megamenu-mlid-4746" class="megamenu-item megamenu-item-89 even half-2 leaf-89 "><a href="/catapult">New collaboration for CAR-T cell immuno-oncology therapy development</a></li><li id="megamenu-mlid-3201" class="megamenu-item megamenu-item-90 odd half-2 leaf-90 "><a href="/new-offices-crt-inc">New offices for CRT Inc.</a></li><li id="megamenu-mlid-1316" class="megamenu-item megamenu-item-91 even half-2 leaf-91 "><a href="/helix-2014">ON Helix 2014</a></li><li id="megamenu-mlid-1591" class="megamenu-item megamenu-item-92 odd half-2 leaf-92 "><a href="/pdx-models-workshop-2014">PDX Models Workshop 2014</a></li><li id="megamenu-mlid-1127" class="megamenu-item megamenu-item-93 even half-2 leaf-93 "><a href="/pdx-workshop">PDX Workshop</a></li><li id="megamenu-mlid-1311" class="megamenu-item megamenu-item-94 odd half-2 leaf-94 "><a href="/preclinical-models-network-taking-shape">Preclinical models network taking shape</a></li><li id="megamenu-mlid-1229" class="megamenu-item megamenu-item-95 even half-2 leaf-95 "><a href="/promising-results-phase-1-trial-lead-immatics-continue-work-vaccine-ima950-glioblastoma">Promising results in Phase 1 trial lead immatics to continue work on vaccine (IMA950) for glioblastoma</a></li><li id="megamenu-mlid-2876" class="megamenu-item megamenu-item-96 odd half-2 leaf-96 "><a href="/rd-alliance-restructure-presents-new-dna-damage-response-partnership-opportunities-including-leading">R&amp;D alliance restructure presents new DNA damage response partnership opportunities including leading PolQ project</a></li><li id="megamenu-mlid-3171" class="megamenu-item megamenu-item-97 even half-2 leaf-97 "><a href="/Sachs">Sachs 15th Annual Biotech in Europe Forum</a></li><li id="megamenu-mlid-6381" class="megamenu-item megamenu-item-98 odd half-2 leaf-98 "><a href="/storm-therapeutics-secures-%C2%A312m-investment-cancer-therapeutics">Storm Therapeutics secures £12m investment for cancer therapeutics</a></li><li id="megamenu-mlid-1222" class="megamenu-item megamenu-item-99 even half-2 leaf-99 "><a href="/successful-completion-phase-i-trial-gsk1070916">Successful completion of the Phase I trial of GSK1070916</a></li><li id="megamenu-mlid-2811" class="megamenu-item megamenu-item-100 odd half-2 leaf-100 "><a href="/three-new-companies-join-cancer-research-uk-abcodia-collaboration-identify-blood-markers-early">Three new companies join Cancer Research UK-Abcodia collaboration to identify blood markers for early cancer detection</a></li><li id="megamenu-mlid-1696" class="megamenu-item megamenu-item-101 even half-2 leaf-101 "><a href="/two-cancer-research-technology-deals-shortlisted-leading-industry-awards">Two Cancer Research Technology deals shortlisted for leading industry awards</a></li><li id="megamenu-mlid-2851" class="megamenu-item megamenu-item-102 odd half-2 leaf-102 "><a href="/valneva-and-blink-therapeutics-confirm-launch-and-funding-blink-biomedical">Valneva and BliNK Therapeutics confirm launch and funding of BliNK Biomedical</a></li><li id="megamenu-mlid-1321" class="megamenu-item megamenu-item-103 even half-2 leaf-103 "><a href="/world-pharma-licensing-congress-2014">World Pharma Licensing Congress 2014</a></li><li id="megamenu-mlid-2791" class="megamenu-item megamenu-item-104 odd half-2 leaf-104 last last"><a href="/%C2%A350m-crt-pioneer-fund-announces-investment-develop-lung-cancer-drugs-cancer-research-uks-manchester">£50M CRT Pioneer Fund announces invest to develop lung cancer drugs at Cancer Research UK&#039;s Manchester Institute</a></li></ul></li><li id="megamenu-mlid-837" class="megamenu-slot megamenu-slot-1 even half-2 leaf-1 last last"><span class="megamenu-slot-title"><a href="/cruk-science">CRUK Science</a></span></li></ul></li><li id="megamenu-mlid-861" class="megamenu-parent menuitem megamenu-parent-6 odd half-2 leaf-6 menu-861 "><a href="/careers">Careers</a><span class="arrow"></span><span class="highlight"></span><ul class="submenu megamenu-bin megamenu-slots-columnar"><li id="megamenu-mlid-862" class="megamenu-slot megamenu-slot-0 odd half-1 leaf-0 first first"><span class="megamenu-slot-title"><a href="/careers">Careers</a></span></li><li id="megamenu-mlid-832" class="megamenu-slot megamenu-slot-1 even half-2 leaf-1 last last"><span class="megamenu-slot-title"><a href="/vacancies">Vacancies</a></span></li></ul></li><li id="megamenu-mlid-838" class="megamenu-parent menuitem megamenu-parent-7 even half-2 leaf-7 last menu-838 last"><a href="/contact-us">Contact Us</a><span class="arrow"></span><span class="highlight"></span><ul class="submenu megamenu-bin megamenu-slots-columnar"><li id="megamenu-mlid-940" class="megamenu-slot megamenu-slot-0 odd half-1 leaf-0 first first last"><span class="megamenu-slot-title"><a href="/contact-us">Contact Us</a></span></li></ul></li></ul></div> </nav> <section role="contentinfo" class="contentsContainer"><div class="row row1"> <section class="block-content span1 carouselIntro"><div class="view view-front-top-carousel-intro view-id-front_top_carousel_intro view-display-id-block view-dom-id-b18caa81ace682b7a8d5f17dc1a54581"><div class="view-content"><div class="views-row views-row-1 views-row-odd views-row-first views-row-last"><div class="views-field views-field-title"><h2 class="field-content title">About Cancer Research Technology</h2></div><div class="views-field views-field-body"><div class="field-content"><p>CRT develops and commercialises exciting new discoveries in cancer research. We’re the meeting point between academia and industry. Our deep understanding of both perspectives enables us to translate promising research into commercial propositions to deliver patient benefit and commercial value that will support further cancer research.</p></div></div><div class="views-field views-field-field-link-top-carousel"><div class="field-content"><a href="http://www.cancertechnology.co.uk/our-company">Read more</a></div></div></div></div></div> </section> <section class="flexslider carousel span2a last"><ul class="slides"><li><div class="content"><h3><p><strong>Exclusive rights</strong> to over £350m of cancer research per year</p></h3>Our marketed drugs include Temodal, Zytiga, Erivedge and Lynparza.</div><div class="carouselimg-container"><img src="/sites/default/files/Home_Carousel_2_Â£300m_Science.png" alt="" class="centreimg"/></div></li><li><div class="content"><h3><p>We speak <strong>your language</strong></p></h3>CRT translates academic research into industry propositions.</div><div class="carouselimg-container"><img src="/sites/default/files/Home_Carousel_1_Language_Alternative.png" alt="" class="centreimg"/></div></li><li><div class="content"><h3><p><strong>£28.5m</strong> in grants and&nbsp;support leveraged last year</p></h3>If a project looks promising, we’ll find a way to move it forward.</div><div class="carouselimg-container"><img src="/sites/default/files/CRT-HP-Carousel-3.png" alt="" class="centreimg"/></div></li><li><div class="content"><h3><p>Realising <strong>clinical</strong> and <strong>commercial</strong> potential</p></h3>We’re driven to achieve maximum patient benefit and market value.</div><div class="carouselimg-container"><img src="/sites/default/files/Home_Carousel_4_Potential_0.png" alt="" class="centreimg"/></div></li><li><div class="content"><h3><p>Many projects, one focus: <strong>cancer</strong></p></h3>Our specialism means we’re more experienced, more knowledgeable and better connected.</div><div class="carouselimg-container"><img src="/sites/default/files/CRT-HP-Carousel-5.png" alt="" class="centreimg"/></div></li></ul> </section></div><div class="row row2"> <section class="block-content span1 first"><div class="view view-front-promo-box view-id-front_promo_box view-display-id-block_1 view-dom-id-66b7a5ed0360e4db61d42d7f4e9dd142"><div class="view-content"><div class="views-row views-row-1 views-row-odd views-row-first views-row-last"><div class="views-field views-field-title"> <span class="field-content">CRT Discovery Laboratories</span></div><div class="views-field views-field-field-image-promo"><div class="field-content"><img typeof="foaf:Image" src="http://www.cancertechnology.co.uk/sites/default/files/Home_Signpost_1_CRTDL_0.png" width="295" height="151" alt="" /></div></div><div class="views-field views-field-body"><div class="field-content"><p>CRT's in-house drug discovery unit, CRT Discovery Laboratories, translates cutting edge science into innovative new therapies for cancer patients.</p></div></div><div class="views-field views-field-field-link-promo"><div class="field-content"><a href="http://www.crtdiscoverylabs.com" class="mainlink">Visit the CRT-DL website</a></div></div></div></div></div> </section> <section class="block-content span1"><div class="view view-front-promo-box view-id-front_promo_box view-display-id-block_2 view-dom-id-9098d9d0a802868a8c029bd9a5cb1704"><div class="view-content"><div class="views-row views-row-1 views-row-odd views-row-first views-row-last"><div class="views-field views-field-title"> <span class="field-content">Licensing Portfolio</span></div><div class="views-field views-field-field-image-promo"><div class="field-content"><img typeof="foaf:Image" src="http://www.cancertechnology.co.uk/sites/default/files/Home_Signpost_2_Licensing-Opps_0.png" width="295" height="151" alt="" /></div></div><div class="views-field views-field-body"><div class="field-content"><p>With exclusive rights to more than £300m of world-class cancer research a year, we’re the gateway to much of the high quality oncology research happening in the UK today.</p></div></div><div class="views-field views-field-field-link-promo"><div class="field-content"><a href="http://www.cancertechnology.co.uk/licensing-opportunites" class="mainlink">View our opportunities</a></div></div></div></div></div> </section> <section class="block-content span1 last"><div class="view view-front-promo-box view-id-front_promo_box view-display-id-block_3 view-dom-id-fec8b05dd18ee698006ffb5d0bd0f843"><div class="view-content"><div class="views-row views-row-1 views-row-odd views-row-first views-row-last"><div class="views-field views-field-title"> <span class="field-content">Have an idea?</span></div><div class="views-field views-field-field-image-promo"><div class="field-content"><img typeof="foaf:Image" src="http://www.cancertechnology.co.uk/sites/default/files/Home_Signpost_3_Idea_0.png" width="295" height="151" alt="" /></div></div><div class="views-field views-field-body"><div class="field-content"><p>Do you have an idea or a discovery with commercial potential? Are you interested in working with industry? Our team can help develop the most promising projects.</p></div></div><div class="views-field views-field-field-link-promo"><div class="field-content"><a href="http://www.cancertechnology.co.uk/have-idea" class="mainlink">Speak to CRT</a></div></div></div></div></div> </section></div><div class="row row3"> <section class="block-tabs span2"><div id="quicktabs-front_page_tabs" class="quicktabs-wrapper quicktabs-style-nostyle"><div class="item-list"><ul class="quicktabs-tabs quicktabs-style-nostyle"><li class="active first"><a href="/node?qt-front_page_tabs=0#qt-front_page_tabs" id="quicktabs-tab-front_page_tabs-0" class="active">LATEST NEWS</a></li><li><a href="/node?qt-front_page_tabs=1#qt-front_page_tabs" id="quicktabs-tab-front_page_tabs-1" class="active">EVENTS</a></li><li class="last"><a href="/node?qt-front_page_tabs=2#qt-front_page_tabs" id="quicktabs-tab-front_page_tabs-2" class="active">TWITTER</a></li></ul></div><div id="quicktabs-container-front_page_tabs" class="quicktabs_main quicktabs-style-nostyle"><div id="quicktabs-tabpage-front_page_tabs-0" class="quicktabs-tabpage "><div class="view view-press-release view-id-press_release view-display-id-block_3 view-dom-id-509803a079a831a97ca45f299da1d802"><div class="view-content"><table class="views-table cols-0" ><tbody><tr class="odd views-row-first"><td class="views-field views-field-field-date-article" > <span class="date-display-single" property="dc:date" datatype="xsd:dateTime" content="2016-08-09T00:00:00+01:00">9 August 2016</span></td><td class="views-field views-field-title" > <a href="/crt-and-alta-innovations-join-forces-commercialise-world-leading-research">CRT and Alta Innovations join forces to commercialise world-leading research</a></td></tr><tr class="even"><td class="views-field views-field-field-date-article" > <span class="date-display-single" property="dc:date" datatype="xsd:dateTime" content="2016-05-26T00:00:00+01:00">26 May 2016</span></td><td class="views-field views-field-title" > <a href="/cancer-research-technology-and-pangaea-biotech-sign-license-agreement-new-cancer-drugs">Cancer Research Technology and Pangaea Biotech sign license agreement for new cancer drugs</a></td></tr><tr class="odd views-row-last"><td class="views-field views-field-field-date-article" > <span class="date-display-single" property="dc:date" datatype="xsd:dateTime" content="2016-04-22T00:00:00+01:00">22 April 2016</span></td><td class="views-field views-field-title" > <a href="/crt-and-university-copenhagen-announce-agreement-adc-therapeutics-develop-antibody-treatments-cancer">CRT and University of Copenhagen announce agreement with ADC Therapeutics to develop antibody treatments for cancer</a></td></tr></tbody></table></div><div class="view-footer"><p><a href="news-and-events">Read more news</a></p></div></div></div><div id="quicktabs-tabpage-front_page_tabs-1" class="quicktabs-tabpage quicktabs-hide"><div class="view view-events view-id-events view-display-id-block_2 view-dom-id-3443010a0dc64dc7afdf17893794a268"><div class="view-filters"><form action="/events" method="get" id="views-exposed-form-events-block-2" accept-charset="UTF-8"><div><div class="views-exposed-form"><div class="views-exposed-widgets clearfix"><div id="edit-field-start-date-event-value-wrapper" class="views-exposed-widget views-widget-filter-field_start_date_event_value"> <label for="edit-field-start-date-event-value"> Filter by Year </label><div class="views-widget"><div id="edit-field-start-date-event-value-value-wrapper"><div id="edit-field-start-date-event-value-value-inside-wrapper"><div class="container-inline-date"><div class="form-item form-type-date-select form-item-field-start-date-event-value-value"><div id="edit-field-start-date-event-value-value" class="date-padding clearfix"><div class="form-item form-type-select form-item-field-start-date-event-value-value-year"> <label class="element-invisible" for="edit-field-start-date-event-value-value-year">Year </label><div class="date-year"><select class="date-year form-select" id="edit-field-start-date-event-value-value-year" name="field_start_date_event_value[value][year]"><option value="" selected="selected">-Year</option><option value="2010">2010</option><option value="2011">2011</option><option value="2012">2012</option><option value="2013">2013</option><option value="2014">2014</option><option value="2015">2015</option><option value="2016">2016</option></select></div></div></div></div></div></div></div></div></div><div class="views-exposed-widget views-submit-button"> <input type="submit" id="edit-submit-events" name="" value="Apply" class="form-submit" /></div></div></div></div></form></div><div class="view-content"><table class="views-table cols-2" ><thead><tr><th class="views-field views-field-field-start-date-event" scope="col"> Start Date</th><th class="views-field views-field-title" scope="col"> Event</th></tr></thead><tbody><tr class="odd views-row-first"><td class="views-field views-field-field-start-date-event" > <span class="date-display-single" property="dc:date" datatype="xsd:dateTime" content="2016-06-06T10:00:00+01:00">06 June 2016</span></td><td class="views-field views-field-title" > <a href="/2016-bio-international-convention">2016 BIO International Convention</a></td></tr><tr class="even"><td class="views-field views-field-field-start-date-event" > <span class="date-display-single" property="dc:date" datatype="xsd:dateTime" content="2016-04-16T09:00:00+01:00">16 April 2016</span></td><td class="views-field views-field-title" > <a href="/AACR2016">AACR Annual Meeting 2016</a></td></tr><tr class="odd"><td class="views-field views-field-field-start-date-event" > <span class="date-display-single" property="dc:date" datatype="xsd:dateTime" content="2016-04-03T20:00:00+01:00">03 April 2016</span></td><td class="views-field views-field-title" > <a href="/BioSpring2016">Bio-Europe Spring 2016</a></td></tr><tr class="even"><td class="views-field views-field-field-start-date-event" > <span class="date-display-single" property="dc:date" datatype="xsd:dateTime" content="2016-02-14T07:00:00+00:00">14 February 2016</span></td><td class="views-field views-field-title" > <a href="/AUTM2016">AUTM 2016 Annual Meeting</a></td></tr><tr class="odd views-row-last"><td class="views-field views-field-field-start-date-event" > <span class="date-display-single" property="dc:date" datatype="xsd:dateTime" content="2016-01-27T09:30:00+00:00">27 January 2016</span></td><td class="views-field views-field-title" > <a href="/StructuralBiology2016">Accelerator Structural Biology Conference 2016</a></td></tr></tbody></table></div><div class="view-footer"><p><a href="news-and-events?qt-news_tabs=3#qt-news_tabs">View upcoming events</a></p></div></div></div><div id="quicktabs-tabpage-front_page_tabs-2" class="quicktabs-tabpage quicktabs-hide">
<script type="text/javascript" src="http://cdn.shopify.com/s/files/1/0189/0346/files/twitterFetcher_v9_min.js?1203"></script>
<div id="twitter">
<script type="text/javascript">twitterFetcher.fetch('373044459551739905', 'tweet', 3, true);</script>
<div id="tweet"></div></div><div class="view-footer"><p><a href="https://twitter.com/CRT_News" target="_blank">Join us on Twitter</a></p></div></div></div></div> </section><section class="block-content block-spotlight span2 last"><div class="view view-front-spotlight-box view-id-front_spotlight_box view-display-id-block_1 view-dom-id-d3d89806b8acbffbe017833673cc69d3"><div class="view-content"><div class="views-row views-row-1 views-row-odd views-row-first views-row-last"><div class="views-field views-field-title-1"><h2 class="field-content title">LATEST DOWNLOADS</h2></div><div class="views-field views-field-field-image-front-spot"><div class="field-content"><img typeof="foaf:Image" src="http://www.cancertechnology.co.uk/sites/default/files/Ximbio_ebook%20cover%20v2%207Mar16.png" width="176" height="135" alt="" /></div></div><div class="views-field views-field-body"><div class="field-content"><p>How can you raise your scientific profile and have a truly lasting impact within the scientific community (all without having to rely solely on your publication record)?</p><p>The answer: tap into the new and growing opportunities offered by the web. This eBook from Ximbio was created to help you do exactly this.”</p></div></div><div class="views-field views-field-field-link-front-spot"><div class="field-content"><a href="http://news.ximbio.com/get-your-ebook-is-there-more-to-science-than-publishing?utm_campaign=Inbound%20Pilot&amp;utm_medium=eBook&amp;utm_source=CRT%20Website" class="mainlink">Download free eBook</a></div></div></div></div></div> </section></div><div class="row row4"> <section class="block-sponsors span3 last"><div class="content"><h3>OUR NETWORK</h3><p>We've established major partnerships with research institutions, pharmas and biotechs of all sizes.</p></div><div class="sponsor-container flexslider"><ul class="sponsorslist slides"><li><ul><li><a href="/our-network"><img src="/sites/default/files/Home_Network-Logo_Forma_Resized.png" alt="Forma" /></a></li><li><a href="/our-network"><img src="/sites/default/files/Home_Network-Logo_LRI.png" alt="CRUK London Research Institute" /></a></li><li><a href="/our-network"><img src="/sites/default/files/Home_Network-Logo_Novartis_Resized.png" alt="Novartis" /></a></li><li class="last"><a href="/our-network"><img src="/sites/default/files/Home_Network-Logo_Imperial.png" alt="Imperial College London" /></a></li></ul></li><li><ul><li><a href="/our-network"><img src="/sites/default/files/Home_Network-Logo_AZ_Resized.png" alt="AstraZeneca" /></a></li><li><a href="/our-network"><img src="/sites/default/files/Home_Network-Logo_CRI.png" alt="CRUK Cambridge Institute" /></a></li><li><a href="/our-network"><img src="/sites/default/files/Home_Network-Logo_Merck-Serono.png" alt="Merck Serono" /></a></li><li class="last"><a href="/our-network"><img src="/sites/default/files/Home_Network-Logo_Southampton.png" alt="University of Southampton" /></a></li></ul></li><li><ul><li><a href="/our-network"><img src="/sites/default/files/Home_Network-Logo_Astex_0.png" alt="Astex" /></a></li><li><a href="/our-network"><img src="/sites/default/files/Home_Network-Logo_Newcastle_0.png" alt="Newcastle University" /></a></li><li><a href="/our-network"><img src="/sites/default/files/Home_Network-Logo_Teva_Resized.png" alt="Teva" /></a></li><li class="last"><a href="/our-network"><img src="/sites/default/files/Home_Network-Logo_Beatson_0.png" alt="Beatson" /></a></li></ul></li><li><ul><li><a href="/our-network"><img src="/sites/default/files/Home_Network-Logo_ICR.png" alt="ICR Logo" /></a></li><li><a href="/our-network"><img src="/sites/default/files/Home_Network-Logo_Paterson.png" alt="CRUK Manchester Logo" /></a></li><li><a href="/our-network"><img src="/sites/default/files/Home_Network-Logo_GSK.png" alt="GSK Logo" /></a></li><li class="last"><a href="/our-network"><img src="/sites/default/files/Home_Network-Logo_GIROB.png" alt="GIROB Logo" /></a></li></ul></li></ul></div> </section></div> </section></div> <footer> <a href="#" id="scrollTop" class="visible-xs-block">Back to top</a><div class="inner"> <section class="column list"><h3>Quick Links</h3><ul><li><a href="/our-company">About CRT</a></li><li><a href="/our-people">Our People</a></li><li><a href="/drug-discovery">Drug Discovery</a></li><li><a href="/licensing-opportunites">Licensing Opportunities</a></li><li><a href="/vacancies">Current Vacancies</a></li></ul> </section> <section class="column address"><h3>Contact us</h3><p>Head Office<br />Angel Building<br />407 St John Street<br />London EC1V 4AD, UK</p><p><a href="tel:+442034696300">+44 (0)20 3469 6300</a><br /><a class="email" href="mailto:enquiries@cancertechnology.com">enquiries@cancertechnology.com</a></p> </section> <section class="column"><h3>Keep up to date</h3><ul class="social"><li class="twitter"><a href="https://twitter.com/CRT_News">Twitter</a></li><li class="linkedin"><a href="http://www.linkedin.com/company/cancer-research-technology">Linkedin</a></li></ul> </section> <section class="column column-last"><h3>Subscribe to our newsletter</h3><div id="mc_embed_signup"><form action="http://cancertechnology.us1.list-manage1.com/subscribe/post?u=b47431487239cc7295fa23cbe&amp;id=4ecfc19117" method="post" id="mc-embedded-subscribe-form" name="mc-embedded-subscribe-form" class="validate" target="_blank" novalidate><div class="mc-field-group"><label for="mce-EMAIL">Email Address</label><input type="text" value="Enter your email address" name="EMAIL" class="required email inner-hint cleartext" id="mce-EMAIL"></div><div id="mce-responses" class="clear"><div class="response" id="mce-error-response" style="display:none"></div><div class="response" id="mce-success-response" style="display:none"></div></div><div class="clear"><input type="submit" value="Submit" name="subscribe" id="mc-embedded-subscribe" class="button submitsubscribe"></div></form></div> </section><div class="footerNav clearfix"><h3>Footer smallprints</h3><ul><li>© Cancer Research Technology 2013</li><li><a href="/terms-conditions" title="Terms &amp; Conditions">Terms &amp; Conditions</a></li><li><a href="/privacy-statement" title="Privacy Statement">Privacy Statement</a></li><li><a href="/cookie-policy" title="Cookie Policy">How We Use Cookies</a></li><li><a href="http://www.cancerresearchuk.org" target="_blank">www.cruk.org</a></li></ul><p><strong>This site uses cookies. <a href="/cookie-policy">Click here</a> to find out more and how to refuse cookies.</strong></p><p>Registered address: Cancer Research Technology Ltd., Angel Building, 407 St John Street, London EC1V 4AD, UK. Registered in England (1626049). VAT registration number GB788 138678. A wholly-owned subsidary of Cancer Research UK, registered charity in England and Wales (1089464), Scotland (SC041666) and the Isle of Man (1103).</p></div></div> </footer><div class="overlay"></div>
<script src="/sites/all/themes/CRT-2013/assets/js/mailchimp.js" type="text/javascript"></script>

<script src="/sites/all/themes/CRT-2013/assets/js/jquery.flexslider-min.js" type="text/javascript"></script>
</div></div>	
	<!-- <div id="bdr"></div> -->
</body>
</html>
